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Around 25% of children with Attention-Deficit/Hyperactivity Disorder (AD/HD) 
have an anxiety disorder (Tannock, 2000), and children with AD/HD are three times 
more likely than children in the general population to have an anxiety disorder (Angold, 
Costello, & Erkanli, 1999). Past research has identified negative or controlling parenting 
practices, parental psychopathology, child externalizing symptoms, and child educational 
difficulties as potential risk factors for anxiety in children with AD/HD. However, the 
mechanisms underlying the relation between AD/HD and anxiety are unclear. The goal of 
this study was to further examine the parent factors related to symptoms of anxiety in 
children with AD/HD. It was hypothesized that parental symptoms of AD/HD and 
inconsistent parenting practices would predict symptoms of anxiety in children with 
AD/HD. Child perceptions of control were also hypothesized to moderate the relation 
between parenting practices and child anxiety symptoms. 
The participants for the study included 28 children between the ages of 8 and 15 
who had been diagnosed with AD/HD and at least one parent. A logistic regression 
analysis indicated that maternal psychopathology predicted a diagnosis of social phobia. 
Post-hoc analyses also indicated that mothers of children with AD/HD and social phobia 
had more symptoms of AD/HD than parents of children with AD/HD only. These 
findings have implications for theoretical understandings of AD/HD with comorbid 
anxiety, future research, and clinical practice with families of children with AD/HD.
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CHAPTER I 
INTRODUCTION 
 
 
 Attention-Deficit/Hyperactivity Disorder (AD/HD) and anxiety disorders are two 
of the most common psychological disorders in children (Costello, Egger, & Angold, 
2005; Costello, Mustillo, Erkanli, Keeler, & Angold, 2003; Shaffer, Fisher, Dulcan, & 
Davies, 1996). These disorders co-occur frequently in the same children; nearly 25% of 
children with AD/HD also have an anxiety disorder, and around 10-15% of children with 
an anxiety disorder also have AD/HD (Kendall et al., 2010; March et al., 2000; Tannock, 
2000). A widely cited meta-analysis demonstrated that the odds of AD/HD and any 
anxiety disorder being comorbid in a community sample range from 2.1 to 4.3, with a 
median of 3.0 (Angold et al., 1999); therefore, a child with AD/HD or anxiety has a three 
times higher chance of having the other disorder than a child without either of these 
disorders. 
Despite the substantial comorbidity1 between AD/HD and anxiety disorders, 
relatively little research has been conducted regarding the factors responsible for the 
overlap between these disorders. Past cross-sectional research has demonstrated that 
                                                 
1 The term “comorbidity” has been used in many ways in the psychological literature (Angold et al., 1999; Kaplan & 
Feinstein, 1974; Lilienfeld, 2003; Lilienfeld, Waldman, & Israel, 1994; Piotrowski, 2007). It has been used to refer to 
the co-occurrence of one or more disorders, though different uses and interpretations of the term have varied with 
respect to whether the disorders must co-occur in time, how many disorders constitute a comorbidity, and whether 
symptoms (as opposed to clinical disorders) should be included. One common definition is two disorders that co-occur 
more frequently than would be expected by chance because they are etiologically related (Kaplan & Feinstein, 1974). 
This is the meaning of comorbidity that was used for the purposes of this project; that is, AD/HD and anxiety disorders 
co-occur in children at a rate that is significantly higher than would be predicted by chance based on their base rates in 
the general population. 
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overprotective and controlling parenting practices, lack of positive parenting, parental 
psychopathology, child educational difficulties, child externalizing behavior, and 
symptoms of inattention are associated with anxiety in children with AD/HD (Acosta et 
al., 2008; Baldwin & Dadds, 2008; Kepley & Ostrander, 2007; McGee, 2007; Moulton, 
2006). These studies have been limited by imprecise measurements of parental 
psychopathology and by the cross-sectional nature of most of this research. 
 Understanding this common comorbidity is important for two reasons. First, 
children with comorbid AD/HD and anxiety have been shown to exhibit greater 
impairment in the domains of life stress and parental psychopathology than children with 
AD/HD only (Jensen, Shervette, Xenakis, & Richters, 1993). Second, children with 
AD/HD and an anxiety diagnosis have been found to respond differently to various 
psychosocial and pharmacological treatments than children with AD/HD only or an 
anxiety disorder only. One notable example of this differential response comes from the 
Multimodal Treatment of AD/HD (MTA) study, which compared behavioral treatment, 
medication, combination treatment (behavioral treatment and medication), and 
community care for the treatment of AD/HD in children. Secondary analyses of these 
data indicated that children with comorbid AD/HD and anxiety responded best to the 
combination treatment with regard to several outcomes, and that the effect sizes for all 
treatments were larger for children with comorbid AD/HD and anxiety than for the 
general sample (March et al., 2000). Therefore, an improved understanding of the risk 
factors for anxiety in children with AD/HD may enhance clinical work with children who 
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have AD/HD and comorbid anxiety and may also suggest unique treatment strategies that 
address these risk factors. 
 As a step towards clarifying the nature of the relationship between AD/HD and 
anxiety in children, this study was designed to further examine parent and parenting 
characteristics that are associated with anxiety in children with AD/HD. Specifically, this 
study examined inconsistent parenting practices as well as parental anxiety, depression, 
and AD/HD as predictors of anxiety in children with AD/HD. As a background to this 
investigation, brief overviews about what is known about AD/HD and anxiety are 
provided, followed by a review of the existing literature regarding theoretical reasons for 
the substantial comorbidity between AD/HD and anxiety and empirical research on this 
topic.
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CHAPTER II 
REVIEW OF THE LITERATURE 
 
 
Attention-Deficit/Hyperactivity Disorder 
 AD/HD is characterized by developmentally deviant levels of inattention, 
hyperactivity, and/or impulsivity (American Psychological Association, 2000). 
Symptoms of inattention include lack of attention to details, making careless mistakes on 
schoolwork, difficulty sustaining attention, difficulty organizing tasks, and being easily 
distracted. Symptoms of hyperactivity include fidgeting with hands or feet, running about 
excessively in situations in which it is inappropriate to do so, acting “as if driven by a 
motor,” and talking excessively. Symptoms of impulsivity include difficulty waiting for a 
turn and interrupting others. 
 In order to meet Diagnostic and Statistical Manual—Fourth Edition—Text 
Revision (DSM-IV-TR; American Psychological Association, 2000) criteria for AD/HD, a 
person must experience functional impairment in two or more domains, including social, 
academic, or occupational functioning, and this impairment must be related to symptoms 
of inattention, hyperactivity, or impulsivity (American Psychological Association, 2000). 
The person must display at least six of nine symptoms of inattention and/or at least six of 
nine symptoms of hyperactivity-impulsivity for at least six months, and these symptoms 
must be developmentally deviant. The symptoms must be present before age seven. 
Lastly, the symptoms must not be better accounted for by another disorder.
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 The average onset of AD/HD occurs between three and five years of age, and 
symptoms of hyperactivity, rather than inattention, are typically observed at this young 
age (Barkley, 2006). Children are likely to be diagnosed with AD/HD after entering 
formalized schooling, when the expectations of sitting still, listening to the teacher, 
following instructions, and sustaining attention are higher than for younger children; 
parents of school-age children may also struggle to help their child organize tasks and 
assignments and complete homework. Longitudinal research following individuals with 
AD/HD has found that while symptoms of hyperactivity may decline some in 
adolescence, 70-80% of children with AD/HD are likely to continue to experience 
significant symptoms of AD/HD into adolescence (Barkley, Fischer, Edelbrock, & 
Smallish, 1990). Regarding persistence of AD/HD into adulthood, research has been 
limited but seems to suggest that many adults diagnosed with AD/HD as children 
continue to experience difficulty with inattention, hyperactivity, and/or impulsivity as 
adults (Barkley, 2006). 
 Though estimates vary based on the assessment methods used and other 
methodological variations, most epidemiological studies have found that approximately 
3-5% of children meet diagnostic criteria for AD/HD (Costello et al., 2003; Shaffer et al., 
1996). Estimates of the ratio of boys to girls with the disorder also vary, but the average 
is 3:1 in non-clinic-referred children and between 5:1 and 9:1 in clinic-referred children 
(Barkley, 2006b). Children with AD/HD are more likely than children in the general 
population to experience difficulties in adaptive functioning, academic and intellectual 
functioning, and family and peer functioning (Frazier, Demaree, & Youngstrom, 2004; 
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Goode, 2002; Nixon, 2001; Stein, Szumowski, Blondis, & Roizen, 1995). Children with 
AD/HD are also more likely to meet criteria for other psychological disorders including 
Oppositional Defiant Disorder (ODD), Conduct Disorder (CD), depression, substance 
abuse, and, as previously reviewed, anxiety (Angold et al., 1999). 
Current theories of the etiology of AD/HD posit that genetic factors that influence 
neurodevelopment likely cause AD/HD (for review, see Bradley & Golden, 2001). 
Family and twin studies have shown that the majority of variation in AD/HD-like 
symptoms can be accounted for by genetics and that other variability is accounted for by 
non-shared environmental factors, such as events that occur prenatally (Barkley, 2006a). 
Neurotransmitter dysfunction, particularly in the dopamine and norepinephrine systems, 
has also been found to be associated with AD/HD and implicated in its etiology (Pliszka, 
McCracken, & Maas, 1996). Genetics and early environmental effects likely contribute to 
structural and functional brain changes that cause the symptoms of AD/HD. 
 Studies of parenting of children with and without AD/HD have found that 
mothers of children with AD/HD were more likely to use power-assertive and controlling 
parenting techniques than parents of children that did not have AD/HD (Gerdes & Hoza, 
2006; Moulton, 2006). Mothers and fathers of children with AD/HD have also been 
found to be less consistent in their parenting practices than parents of children without 
AD/HD (Ellis & Nigg, 2009); this effect was also found even when ODD and CD 
diagnostic status was controlled. Recent research suggests that parental AD/HD 
symptoms may influence parenting. Mothers of children with AD/HD who also had 
AD/HD themselves were less consistent disciplinarians than mothers who did not have 
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AD/HD (Chronis-Tuscano et al., 2008; Murray & Johnston, 2006). Other research 
indicates that maternal responses to child behavior are warmest when the mother and 
child both have high levels of AD/HD symptoms (Psychogiou, Daley, Thompson, & 
Sonuga-Barke, 2008). 
Anxiety Disorders 
 The current DSM-IV defines ten anxiety disorders: Separation Anxiety Disorder 
(SAD), Specific Phobia, Generalized Anxiety Disorder (GAD), Social Phobia (SP), Panic 
Disorder with and without agoraphobia, Agoraphobia without panic disorder, Obsessive-
Compulsive Disorder (OCD), Post-Traumatic Stress Disorder (PTSD), and Acute Stress 
Disorder (American Psychological Association, 2000). Separation Anxiety Disorder can 
only be diagnosed in children; the other anxiety disorders can be diagnosed in children 
and adults. Generalized Anxiety Disorder (GAD) and Social Phobia (SP) are the most 
commonly diagnosed anxiety disorders in children with AD/HD; the other anxiety 
disorders also co-occur with AD/HD, but at lower rates (Elia, Ambrosini, & Berrettini, 
2008; Last, Perrin, Hersen, & Kazdin, 1992; Vance et al., 2002). The present review of 
anxiety disorders in children will therefore focus primarily on GAD and SP. 
 The hallmark feature of GAD is excessive worry and anxiety about a variety of 
events not confined to the specific worries present in other anxiety disorders such as SP 
or OCD. In children, these worries frequently concern health, school, disasters, future 
events, and personal harm (Weems, Silverman, & La Greca, 2000); however, the fears 
are not focused on a single specific object or event as in specific phobias. The DSM-IV-
TR criteria for a diagnosis of GAD require excessive anxiety and worry occurring on 
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most days over a period of six months and about a variety of topics (American 
Psychological Association, 2000). The child must find it difficult to control the worry, 
and in children the worry must be accompanied by at least one of the following physical 
symptoms: restlessness, being easily fatigued, difficulty concentrating, irritability, muscle 
tension, or sleep disturbance. The worry must also cause impairment in one or more 
domains of functioning. The current DSM-IV-TR classification recognizes GAD as a 
disorder that can affect both children and adults. 
 The hallmark feature of SP is an extreme fear of social or performance situations 
(American Psychological Association, 2000). In SP, these types of situations are avoided 
or endured with extreme nervousness or distress, and this anxiety or avoidance must 
interfere significantly with one’s normal functioning. In order to diagnose this disorder in 
a child, the child must show evidence of having the capacity for peer relationships and 
the anxiety must occur in the context of interactions with peers, not just in interactions 
with adults, and the duration of the fear must be at least six months.  
 As with AD/HD, prevalence estimates for anxiety disorders in children vary 
widely due to assessment procedures and other methodological variations. Estimates of 
the prevalence of anxiety disorders in children and adolescents range from 2.8% for a 
point prevalence to lifetime prevalence estimates of 8.7% to 20.7% (Costello, Egger, & 
Angold, 2005). GAD , SAD, and SP are the most common anxiety diagnoses in children 
(Costello et al., 2005). Anxiety disorders commonly co-occur with each other as well. 
Girls are more likely than boys to report an anxiety disorder of some sort, although sex 
differences are not usually large (Costello, Egger, & Angold, 2004). However, this effect 
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has been found to hold even when other factors associated with both sex and anxiety, 
such as self-esteem, social support, social competence, social support, and physical 
health, are controlled (Lewinsohn, Gotlib, Lewinsohn, Seeley, & Allen, 1998). 
An analysis of the developmental course of anxiety disorders indicated that there 
are not yet well-defined developmental pathways that illustrate consistency or change in 
these disorders over time (Warren & Sroufe 2004). The average ages of onset for GAD 
and SP appear to be in pre-adolescence or early adolescence. The average age of onset for 
GAD in clinical samples, based on retrospective recall, ranges from 6.5 to 23.6 
(Anderson, Noyes, & Crowe, 1984; Hammerness et al., 2008; Last, Hersen, Kazdin, & 
Finkelstein, 1987; Massion, Warshaw, & Keller, 1993; Noyes, Woodman, Garvey, & 
Cook, 1992; Woodman, Noyes, Black, Schlosser, & Yagla, 1999). Estimates of the age of 
onset for SP in clinical samples indicate that the average age of onset for SP is slightly 
older, around age 11 (Last et al., 1992). The ages of onset for individual participants in 
these studies extends from early childhood through late adulthood.  Some data suggest 
that onset of GAD peaks between the ages of 5 and 8 as well as between the ages of 16 
and 19 (Campbell, Brown, & Grisham, 2003). Several studies have also reported that 
older children and adolescents tend to have more symptoms of GAD than younger 
children and that GAD is more likely than other anxiety disorders to have a gradual, 
rather than sudden, onset (Anderson et al., 1984; Tracey, Chorpita, Douban, & Barlow, 
1997). Over the lifespan, the course of both GAD and SP is generally thought to be 
chronic, although the anxiety may fluctuate based on life demands and stressors 
(American Psychological Association, 2000). 
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 Several factors have been implicated in the etiology of anxiety disorders in 
children, including genetics, temperament, parental anxiety, and parenting practices. A 
study of twins has shown that the heritability of GAD is around .25 (Ehringer, Rhee, 
Young, Corley, & Hewitt, 2006). There is also a relation between the temperamental 
feature of behavioral inhibition (BI) and increased risk for anxiety disorders (Flannery-
Schroeder, 2004). BI is generally associated with irritability, fearfulness, shyness, and 
withdrawal in children, and it is believed to be highly heritable (Robinson, Kagan, 
Reznick, & Corley, 1992). Children who display BI in infancy or toddlerhood are more 
likely than uninhibited children to develop anxiety disorders in later childhood 
(Rosenbaum, Biederman, Bolduc-Murphy, & Faraone, 1993). In addition, children that 
express stable BI across early childhood are more likely to experience anxiety disorders 
in childhood (Hirshfeld, Rosenbaum, Biederman, & Bolduc, 1992). It is important to note 
that while BI is a risk factor for the development of anxiety disorders, not all children 
who are behaviorally inhibited as young children go on to develop clinically-significant 
anxiety disorders; Manassis, Hudson, Webb, and Albano (2004) note that while BI is a 
risk factor for the development of anxiety disorders in children, other factors must also be 
considered in predicting or explaining the development of anxiety disorders in children. 
Family factors are also thought to play an important role in the etiology of anxiety 
disorders. Research has consistently shown that a harsh, controlling, or overprotective 
parenting style is associated with childhood anxiety disorders across cultures (Bayer, 
Sanson, & Hemphill, 2006; Heider et al., 2008; Manassis, Hudson, Webb, & Albano, 
2004; Silva, Dorso, Azhar, & Renk, 2007). Specifically, a meta-analysis of the literature 
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on parenting style and anxiety disorders suggests that the parenting factors of control and 
autonomy-granting account for more of the variance in childhood anxiety than parental 
warmth (McLeod, Wood, & Weisz, 2007). Lastly, robust findings in numerous studies 
have demonstrated that children with anxiety are also likely to have parents or other 
relatives with anxiety disorders (Marks, 1986). While this phenomenon may be partly 
explained by the genetic heritability of a predisposition for anxiety, family influences on 
anxiety are also thought to occur through processes such as modeling and information 
transfer (Beidel & Turner, 2005). 
 Several integrated models of the etiology of anxiety disorders have been 
proposed. Chorpita and Barlow’s (1998) model of anxiety development (see Figure 1) is 
widely cited in the anxiety literature and integrates biological, temperamental, and 
environmental factors to show how a child may progress from having a behaviorally 
inhibited style in early childhood to clinically significant anxiety in later development. 
The model proposes that the experience of uncontrollable events during early 
development influences children’s perceptions of control. These perceptions of low 
control lead to increased behavioral inhibition, which is associated with particular 
somatic correlates including heightened activity of the hypothalamic-pituitary-adrenal 
(HPA) axis, reticular activating system (RAS), and sympathetic nervous system. During 
later development, perceptions of low control may intensify the activity of these 
physiological correlates. Furthermore, perceptions of low control and experiences of low 
control are learned, so that processing of experiences during later development is biased 
by earlier memories of uncontrollable experiences. In early development, perceptions of 
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control are thought to mediate the relationship between stimuli and inhibition or anxiety; 
in later development, perceptions of control are thought to moderate this relationship. In a 
study designed to test this model, Choate-Summers (2006) found that an external locus of 
control (a child’s perception that their actions and other events are outside of their own 
control) was associated with anxiety in children and adolescents; further, locus of control 
mediated the relation between a behaviorally-controlling family environment and anxiety 
in children and moderated this relationship in adolescents. This research supports various 
parts of Chorpita and Barlow’s (1998) model. 
Comorbid AD/HD and Anxiety: Possible Developmental Pathways 
Although the existence of substantial comorbidity between AD/HD and anxiety is 
well-documented, the reasons for the comorbidity are not well-understood. Tannock 
(2000) and Lilienfeld (2003) have both outlined several possible reasons for the 
substantial comorbidity between AD/HD and anxiety in children, many of which are not 
supported by current research in this area. One of these possibilities is that anxiety may 
develop first and cause inattention; however, these attention problems do not share the 
same neuro-developmental etiological process that AD/HD is thought to have. A second 
possibility is that the substantial comorbidity between AD/HD and anxiety disorders 
could be caused by shared risk factors for both disorders. Several studies have 
investigated this possibility; however, no shared genetic or executive functioning risk 
factors have been identified (Biederman, Faraone, Keenan, Steingard, & Tsuang, 1991; 
Braaten et al., 2003; Perrin & Last, 1996; Piper, 2007; Rommelse et al., 2009). A third 
possible explanation is that what is currently conceptualized and diagnosed as comorbid 
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AD/HD and anxiety could be a distinctive disorder with its own etiology, course, and 
treatment response. Jensen, Martin, and Cantwell (1997) reviewed the literature on 
AD/HD and comorbid anxiety and suggested that this presentation may be better 
characterized as a distinctive disorder; however, this idea does not seem to have gained 
support in the empirical literature or in reviews published since this time.  
One possible explanation for the overlap between AD/HD and anxiety that has 
gained support is that AD/HD emerges first and makes the development of anxiety more 
likely. The symptoms of AD/HD and/or the persistent difficulties encountered by a child 
with AD/HD may contribute to the development of anxiety in some children. 
Longitudinal research has demonstrated that AD/HD status predicts anxiety in later 
development, which supports the possibility that having AD/HD makes the development 
of anxiety more likely. A longitudinal study of a diverse sample found an odds ratio of 
10.3 (95% CI=2.7-39.3) for children with AD/HD to have anxiety or depression at eight-
year follow-up (Bussing, Mason, Bell, Porter, & Garvan, 2010). Further, five-year and 
ten-year follow-ups indicate that girls who met DSM-III-R criteria for Attention Deficit 
Disorder (ADD) experienced anxiety disorders, as well as mood disorders, antisocial 
disorders, and substance use disorders, at a much greater rate than girls who did not meet 
criteria for ADD at baseline (Biederman et al., 2006; Biederman et al., 2010). 
Consistent with this possibility, the average ages of onset and etiologies of 
AD/HD and GAD suggest that clinically significant symptoms of anxiety may develop 
after the onset of AD/HD; this sequence has recently been termed a “post-comorbidity” 
(Taurines, 2010). Epidemiological studies have shown that the average age of onset for 
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AD/HD is between three and five years old (Barkley, 2006b), whereas the average age of 
onset for GAD is in early adolescence (Anderson, Noyes, & Crowe, 1984; Hammerness 
et al., 2008; Last, Hersen, Kazdin, & Finkelstein, 1987; Massion, Warshaw, & Keller, 
1993; Noyes, Woodman, Garvey, & Cook, 1992; Woodman, Noyes, Black, Schlosser, & 
Yagla, 1999). In an epidemiological study of preschool children, 12.8% of children had 
met criteria for any subtype of AD/HD in the previous three months, whereas less than 
1% of children had met criteria for GAD in the previous three months (Lavigne, 
LeBailly, Hopkins, Gouze, & Binns, 2009). Further, the etiology of AD/HD is thought to 
be primarily biological and neurological, whereas the etiology of GAD and anxiety more 
generally is thought to be influenced by a combination of family and environmental 
factors, genetics, and temperament. Specifically, Chorpita and Barlow’s (1998) model of 
anxiety development theorizes that early and repeated experiences with uncontrollable or 
unpredictable events contribute to external loci of control in both early and later 
development; that is, symptoms of anxiety are present in later development due to 
experiences with uncontrollable or unpredictable events in earlier childhood. Based on 
these factors, it is plausible that many children may develop anxiety as a result of the 
persistent difficulties encountered by a child with AD/HD. 
Recent studies have begun to examine potential risk and protective factors for 
anxiety disorders in children with AD/HD. In a cross-sectional study of a community 
sample, parents of children who had comorbid AD/HD and anxiety were less 
encouraging of independence and more controlling than parents of children who had 
AD/HD only and parents of control children (Kepley & Ostrander, 2007). Another cross-
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sectional study of children with AD/HD found that negative parenting practices, along 
with special education services, predicted greater anxiety symptoms; that negative 
cognitive errors predicted a diagnosis of GAD; and that gender, negative cognitive errors, 
a more external locus of control, and maternal psychopathology predicted a diagnosis of 
SP (McGee, 2007). Similarly, a cross-sectional study in a large sample of children with 
AD/HD found that maternal, but not paternal, symptoms of anxiety as well as 
overprotective parenting and lack of positive parenting predicted anxiety diagnoses in 
children (Pfiffner & McBurnett, 2006). Further, a study of children with AD/HD found 
that symptoms of AD/HD and parenting factors (including parenting style, discipline 
techniques, and attributions regarding child behavior) predicted child symptoms of 
anxiety, but that the interaction between these two factors did not predict additional 
variance above and beyond the main effects (Moulton, 2006). Only one longitudinal 
study has been conducted on this topic; this study found that child temperament and 
externalizing symptoms at baseline were associated with comorbid AD/HD and anxiety 
symptoms at one-year follow-up (Baldwin & Dadds, 2008). Notably, several studies have 
found that parent factors, such as parental psychopathology and negative or controlling 
parenting styles, are associated with anxiety in children with AD/HD. It is important to 
interpret findings from these cross-sectional studies cautiously, since these potential risk 
factors may have preceded the symptoms of anxiety, developed at the same time as the 
symptoms of anxiety, or appeared after the symptoms of anxiety. However, it appears 
that further investigation of these parent factors may be warranted, particularly with 
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regard to identifying mechanisms that may help to explain the connection between parent 
factors and anxiety in a population of children with AD/HD. 
Goals and Hypotheses of the Present Study 
In review, AD/HD and anxiety disorders are common disorders in childhood and 
commonly co-occur (Tannock, 2000); children with AD/HD are three times more likely 
than children in the general population to develop an anxiety disorder (Angold et al., 
1999). Although there are several potential developmental pathways for how a child 
could develop both AD/HD and an anxiety disorder (Tannock, 2000), current research 
findings point towards children developing AD/HD first and developing an anxiety 
disorder in later childhood or adolescence. Previous research in this area has identified 
controlling and negative parenting practices, maternal psychopathology, child negative 
cognitive errors, child locus of control, child temperament, and child externalizing 
disorders as predictors of anxiety in children with AD/HD. Because parenting practices 
and parental psychopathology have been associated with both AD/HD and anxiety in 
children, further investigation of these parent-related variables is warranted in order to 
determine whether they may help to explain the substantial comorbidity between AD/HD 
and anxiety. 
The overall aims of this project, therefore, were to anchor this research on the risk 
factors for anxiety in children with AD/HD within a theoretical framework and to expand 
on the existing research. Chorpita and Barlow’s (1998) model of anxiety development 
hypothesizes that exposure to events that are perceived as unpredictable in early 
development contributes to later anxiety; it is possible that children with AD/HD 
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experience many unpredictable events in childhood, both as a direct result of their 
symptoms of inattention, hyperactivity, and impulsivity, and as a result of the other 
persistent difficulties encountered by a child with AD/HD. In particular, parents of 
children with AD/HD are more likely to use inconsistent parenting practices (Ellis & 
Nigg, 2009). Parents of children with AD/HD who also have AD/HD themselves have 
also been found to use less consistent discipline than parents who do not have AD/HD 
(Chronis-Tuscano et al., 2008; Murray & Johnston, 2006). Inconsistent parenting may be 
experienced by children as unpredictable or uncontrollable. Chorpita and Barlow’s model 
of anxiety development also proposes that locus of control moderates children’s 
experiences of unpredictable events in later development. Based on these theoretical 
considerations and empirical findings, a proposed model for anxiety development in 
children with AD/HD (see Figure 2) illustrates the hypotheses of this study. 
 In accordance with the previously reviewed literature and the proposed model, the 
hypotheses of this study were as follows. 
Hypothesis 1: In the domain of parenting practices, it was predicted that 
inconsistent parenting practices would be associated with increased anxiety in children 
with AD/HD. Initial evidence suggests that parents of children with AD/HD use more 
inconsistent parenting practices than parents of healthy control children (Ellis & Nigg, 
2009); however, inconsistent parenting has not been examined as a risk factor for anxiety 
in children with AD/HD. To the extent that inconsistent parenting may expose children to 
events that they experience as unpredictable, children who experience more inconsistent 
parenting may experience more anxiety. 
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 Hypothesis 2: In the domain of parental psychopathology, it was predicted that 
parental AD/HD symptoms would account for unique variance in child anxiety when 
parental anxiety and depression are accounted for. A plethora of past research has found 
an association between parental anxiety and depression and child anxiety; however, the 
role of parental AD/HD is of particular interest since many parents of children with 
AD/HD also have AD/HD. Some research suggests that parents who have AD/HD are 
less consistent disciplinarians (Chronis-Tuscano et al., 2008; Murray & Johnston, 2006); 
therefore, parental AD/HD symptoms may impact child anxiety indirectly through an 
association with inconsistent parenting practices. 
Hypothesis 3: In the past, locus of control has been hypothesized to mediate the 
relationship between parenting and anxiety in early development, and to moderate the 
relationship between parenting and anxiety in later development (Chorpita & Barlow, 
1998). While past research has shown that locus of control is a predictor of anxiety in 
children with AD/HD, locus of control has not been explored as a mediator or moderator 
in past research on anxiety in children with AD/HD (McGee, 2007). In this study of 
children who are in late childhood and early adolescence, locus of control was 
hypothesized to moderate the relationship between inconsistent parenting practices and 
child anxiety. 
Hypothesis 4: In order to shed further light on the previous mixed findings 
regarding the timing of the onset of AD/HD and symptoms of anxiety, the present study 
collected retrospective reports from parents about the ages of onset of AD/HD, GAD, and 
SP (as applicable for each child). It was hypothesized that parents would report that 
 
19 
 
symptoms of AD/HD were present at an earlier age than symptoms of either anxiety 
disorder. 
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CHAPTER III 
METHODS 
 
 
Participants 
 The participants for the study included a clinical sample of children with AD/HD. 
Inclusion criteria for the study were as follows: the child must meet research criteria for 
AD/HD (any subtype), be between the ages of 8 and 15 (inclusive), and have at least one 
parent or guardian who is willing to participate. In order to meet research criteria for 
AD/HD, the child must display at least six of nine symptoms of inattention and/or six of 
nine symptoms of hyperactivity-impulsivity on the AD/HD module of the Computerized 
Diagnostic Interview Schedule for Children—IV (C-DISC-IV), the ADHD Rating Scale 
(ADHD-RS), or the Conners Comprehensive Behavior Rating Scale (CBRS). These 
symptoms must also be developmentally deviant (t = 65 or 94th percentile) based on 
parent ratings on the ADHD-RS or the Conners Comprehensive Behavior Rating Scales 
(CBRS). When the ADHD-RS or CBRS was used to establish the symptom count, the 
other rating scale was used to establish developmental deviance. 
Participants were recruited from the AD/HD Clinic at UNCG and various private 
practices, schools, and community organizations. A total of 30 participants completed all 
study procedures. Of these participants, 4 did not meet the research study criteria for 
AD/HD. The C-DISC-IV, ADHD-RS, and CBRS scores for these four participants were 
reviewed, and the data for two of these participants were included in the subsequent data 
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analysis. One of these participants had received a clinical diagnosis of AD/HD at the 
AD/HD Clinic at UNCG and authorized the researcher to view the ADHD-RS and CBRS 
ratings from their clinical chart. This participant met the symptom count and 
developmental deviance criteria based on the ADHD-RS and CBRS ratings provided by 
the child’s father and the child’s teachers. The second participant met the symptom count 
criterion for inattention but was at the 90th percentile for ADHD-RS inattention severity. 
The remaining two participants were excluded from further analyses. An additional eight 
families expressed serious interest in participating in the study but did not come to the 
scheduled research visit; these families were re-contacted and were either unable to be 
contacted by phone or decided that they were no longer interested in participation. 
A summary of the sample can be found in Table 1. Child participants ranged in 
age from 8.08 years to 15.50 years (M = 10.56, SD = 3.53) and ranged in grade from 2nd 
to 9th (M = 4.64, SD = 1.85). Seventy-one percent (n = 20) of the participants were male. 
Parents were asked to report on their child’s race/ethnicity; 71.43% (n = 20) of 
participants were Caucasian, 10.71% (n = 3) of participants were African-American, 
10.71% (n = 3) of participants were multiracial, 3.57% (n = 1) were Asian-American or 
Asian, and 3.57% (n = 1) did not report race or ethnicity. Eighty-five-point-seven-one 
percent (n = 24) of the participants lived with both parents, and 14.29% (n = 4) of the 
participants lived with their mother only. According to mother report, 82.14% (n = 23) of 
the participants were taking at least one medication for the management of AD/HD 
symptoms. Of the total sample, 75.00% (n = 21) of participants were taking stimulant 
medication and 21.43% (n = 6) were taking non-stimulant medication for AD/HD; 
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14.29% (n = 4) of the sample were taking both stimulant and non-stimulant medication 
for AD/HD. 
When applicable, both parents were invited and encouraged to participate in the 
study; however, only one parent was required to participate. Mothers participated with 
each of the child participants. The mothers in the sample ranged in age from 27 years to 
62 years (M = 42.32 years; SD = 7.05 years). Overall, the educational status of the 
mothers indicated that this was a highly educated parent sample. In terms of educational 
level, 39.29% (n = 11) of the mothers had completed college and 28.57% (n = 8) of the 
mothers had completed a graduate degree; 7.14% (n = 2) of the mothers did not complete 
high school, 7.14% (n = 2) completed high school, and 17.86% (n = 5) completed some 
college or an associate’s degree. Seven fathers also participated in the project. These 
fathers ranged in age from 35 to 49 (M = 43.29, SD = 5.22). In terms of educational level, 
42.86% (n = 3) of the fathers reported that they had completed college, 28.57% (n = 2) of 
the fathers reported that they had completed graduate degrees, and 28.57% (n = 2) of the 
fathers reported that they had completed some college. 
Materials 
AD/HD Diagnostic Status 
 Computerized Diagnostic Interview Schedule for Children-IV (C-DISC-IV; 
Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000). The C-DISC-IV is a 
psychometrically sound structured diagnostic interview that assesses DSM-IV Axis I 
disorders in children. It is administered in a computerized format to parents or children, 
and answers are given in a yes/no format. For the purposes of this study, the clinician-
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administered version was conducted with mothers. Each question was aloud to the 
mother as it was presented on the computer, and the exact response that the mother 
provided was entered. Parental responses to the AD/HD module were used to assess the 
presence of AD/HD. 
 Conners Comprehensive Behavior Rating Scale (CBRS; Conners, 2008). The 
CBRS is a broad-band rating scale system of children’s behavior. It includes parent and 
teacher report forms for children and adolescents ages 6-18, and self-report forms for 
children and adolescents ages 8-18. The parent report form has 203 items, the teacher 
report form has 204 items, and the self-report form has 179 items. The measure consists 
of 28 scales, including several scales that correspond to DSM-IV disorders and symptom 
counts. Of particular interest to this project were the ADHD hyperactive-impulsive and 
ADHD inattentive subscales. The generalized anxiety disorder, social phobia, and 
separation anxiety disorder subscales were also used for post-hoc analyses. The Conners 
CBRS has been shown to have good reliability and validity. In the present study, the 
parent form (CBRS-P) was administered to mothers. The symptom counts and t-scores on 
the parent-rated AD/HD inattentive and AD/HD hyperactive-impulsive subscales were 
used to establish the symptom count and developmental deviance of these symptoms in 
relation to the diagnosis of AD/HD. 
 ADHD Rating Scale (ADHD-RS; DuPaul et al., 1998). The ADHD-RS is a 
narrow-band rating scale of the symptoms of AD/HD that is based on the DSM-IV criteria 
for the disorder. It is appropriate for use with children and adolescents age 5 to 17. Each 
of the 18 items is rated on a four-point scale ranging from 0 (never or rarely a problem) to 
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3 (very often a problem). The odd-numbered items correspond to the inattention scale, 
and the even-numbered items correspond to the hyperactive-impulsive scale. Each scale 
yields both a symptom count (number of items scored at a 2 or 3) ranging from 0 to 9 and 
a severity scale (with higher numbers indicating higher severity) ranging from 0 to 27. 
The ADHD-RS has been shown to have good reliability and validity (DuPaul et al., 
1998). The ADHD-RS was administered to mothers in this study. The symptom counts 
and severity percentiles on this measure were used to assess the symptom count and 
developmental deviance of inattentive and hyperactive-impulsive behaviors in relation to 
the diagnosis of AD/HD. 
Outcome Variables 
 Multidimensional Anxiety Scale for Children (MASC; March, Parker, Sullivan, 
& Stallings, 1997). The MASC is a measure of a broad range of anxiety symptoms that is 
designed for use with children ages 8 to 17. The informant rates each of the 39 items on a 
four-point scale (never, rarely, sometimes, or often). It contains four factors, three of 
which contain two sub-factors each: physical symptoms (tense/restless and 
somatic/autonomic), social anxiety (humiliation/rejection and public performance fears), 
harm avoidance (perfectionism and anxious coping), and separation anxiety. A 
confirmatory factor analysis using a sample of children with AD/HD replicated these 
factors, demonstrating that this measure is a valid measure of anxiety in this population 
(March et al., 1999). It has good reliability and validity (March et al., 1997). Although 
norms exist only for the child-report version of the MASC, a study of the MASC in a 
community sample demonstrated that the MASC parent-report (MASC-P) is reliable and 
 
25 
 
has the same factor structure as the MASC child self-report (MASC-C) (Baldwin & 
Dadds, 2007). The MASC-C t-scores and MASC-P raw scores were used in this study to 
assess dimensional symptoms of child anxiety. 
 Computerized Diagnostic Interview Schedule for Children-IV (C-DISC-IV). The 
GAD and SP modules were administered to mothers. 
Predictor Variables 
 Inconsistent parenting was assessed with the Parenting Alliance Inventory (PAI) 
and the inconsistent discipline subscale of the Alabama Parenting Questionnaire (APQ). 
These are commonly used scales in the study of parenting. 
Alabama Parenting Questionnaire (APQ; Shelton, Frick, & Wootton, 1996). The 
APQ is a measure of parenting practices, appropriate for use with parents of children who 
are between the ages of six and thirteen. The parent rates each of the 42 items on a five-
point scale (occurs never, occasionally, sometimes, almost always, or always). The APQ 
has five scales, including involvement, positive parenting, poor monitoring/supervision, 
inconsistent discipline, and corporal punishment. It has been found to have adequate 
reliability and validity (Shelton et al., 1996). The APQ was administered to mothers in 
this study and the z-score of the inconsistent discipline scale was used as a measure of 
inconsistent parenting practices. 
 Parenting Alliance Inventory (PAI; Abidin & Brunner, 1995). The PAI is a 
narrow-band rating scale of the degree to which a parent believes that he/she has a sound 
working relationship with the child’s other parent. Each of the 20 items is rated on a five-
point scale ranging from 1 (strongly disagree) to 5 (strongly agree). The item scores are 
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summed to calculate a total score ranging from 20 to 100. The PAI has been shown to 
have good reliability and validity and correlates with other established measures of 
marital adjustment, parenting style, and parenting stress (Abidin & Brunner, 1995). The 
PAI was administered to mothers in this study as a measure of inter-parent parenting 
consistency. 
 Parental symptoms of anxiety, depression, and AD/HD were assessed via narrow-
band measures of psychopathology. 
 Conners’ Adult ADHD Rating Scales (CAARS; Conners et al., 1999). The 
CAARS is a narrow-band measure of adult AD/HD symptoms. It is appropriate for use 
with adults age 18 to 81 years. Each of the 42 items is rated on a four-point scale from 0 
(not at all, never) to 3 (very much, very frequently). A factor analysis showed that the 
scale has four factors, covering both the core symptoms of AD/HD as well as associated 
features: inattention/cognitive problems, hyperactivity/restlessness, impulsivity/emotional 
lability, and problems with self-concept (Conners et al., 1999). The scale has been shown 
to have good reliability and validity, and high sensitivity and specificity (Erhardt, 
Epstein, Conners, Parker, & Sitarenios, 1999). The CAARS was administered to mothers 
and fathers in this study, and the DSM-IV AD/HD Symptoms subscale was used as a 
measure of parental AD/HD symptoms. 
 Beck Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988). The BAI is 
a narrow-band measure of anxiety designed for use with adults. Each of the 21 items is 
rated on a four-point scale ranging from 0 (not at all) to 3 (severely), and the items are 
summed for a total score ranging from 0 to 63. A higher score represents a greater 
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severity of anxiety symptoms. It has been shown to have good reliability and validity and 
it is only moderately correlated with measures of depression, showing that it can 
discriminate between depression and anxiety (Beck et al., 1988). It has also been shown 
to correlate with physiological measures of anxiety (Borden, Peterson, & Jackson, 1991). 
The BAI was administered to mothers and fathers in this study as a measure of parental 
anxiety symptoms. 
 Beck Depression Inventory (BDI; Beck, Steer, & Garbin, 1988). The BDI is a 
narrow-band measure of depression designed for use with adults. Each of the 21 items is 
rated on a four-point scale ranging from 0 (not at all) to 3 (severely), and the items are 
summed for a total score ranging from 0 to 63. A higher score represents a greater 
severity of depression symptoms. It has been shown to have good reliability and validity, 
and it is only moderately correlated with measures of anxiety (Beck et al., 1988). The 
BDI was administered to mothers and fathers in this study as a measure of parental 
depression symptoms. 
 As noted previously, locus of control is considered an important construct in 
understanding child anxiety. Locus of control is commonly assessed in children using the 
Nowicki-Strickland Locus of Control Scale (NSLOC). 
 Nowicki-Strickland Locus of Control Scale (NSLOC; Nowicki & Strickland, 
1973). The NSLOC is a measure of locus of control that is appropriate for children ages 
8-17. The responses to each of the 40 items are given in a yes/no format. Responses are 
scored as a 0 or 1 and these scores are summed for a total score ranging from 0 to 40. 
Higher scores on the scale represent a more external locus of control. The NSLOC has 
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adequate reliability and validity (Nowicki & Strickland, 1973). The NSLOC was 
administered to children in this study as a measure of locus of control. 
Procedure 
 The UNCG Institutional Review Board (IRB) approved this study before 
recruitment began. Participants were recruited in several ways. The student researcher 
contacted past clients of the AD/HD Clinic at UNCG who met inclusion criteria in order 
to invite them to participate. Participants were also recruited from community 
organizations such as the AD/HD Parent Support Group, Greensboro Day School, and the 
Hill Center. The student researcher also made contact with six clinicians in the 
community in order to share information about the study and facilitate recruitment. An 
advertisement for this study as well as three others taking place at the AD/HD Clinic at 
UNCG appeared in the January 2011 and February 2011 issues of Piedmont Parent 
magazine. Of the final sample included in the analyses, 35.7% (n = 10) of the participants 
were recruited from the AD/HD Parent Support Group, 32.1% (n = 9) were recruited 
from the AD/HD Clinic at UNCG, 25.0% (n = 7) had responded to the Piedmont Parent 
advertisement, and 7.1% (n = 2) were from other or unknown recruitment sources. 
Study participation was completed in one or two visits at the AD/HD Clinic at 
UNCG or other mutually convenient location. The student researcher explained all study 
procedures to the child and parents and obtained written child assent and parent consent 
for participation in the study before completing any other study procedures (see 
Appendices A-C). Participants who had previously completed an evaluation at the 
AD/HD Clinic in the six months prior to study participation were asked to sign a release 
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allowing the student researcher to access the ADHD-RS, CBRS, and C-DISC-IV from 
the evaluation so that these measures did not need to be repeated. Parents were given a 
photocopy of the signed assent, consent, and release forms. A summary of the measures 
that participants completed can be found in Appendix A. Children completed the NSLOC 
and MASC-C. Mothers completed a demographic information form, the DISC-IV 
AD/HD and GAD modules, CBRS, ADHD-RS, PAI, APQ, CAARS, BAI, BDI, and 
MASC-P. As many of the child participants were taking medications for the management 
of AD/HD, mothers were instructed to complete all ratings of their child’s behavior based 
on the child’s behavior when he/she is not taking medication. Participating fathers 
completed the BAI, BDI, and CAARS. For families who had already undergone an 
evaluation at the AD/HD Clinic, completion of the study procedures typically took 
approximately 45 minutes. For participants who had not received an evaluation at the 
AD/HD Clinic in the six months prior to study participation, completion of the study 
procedures typically took one-and-a-half to two hours. Upon completion of the study 
procedures, families received a $10 gift card. The student researcher also provided each 
family with a feedback letter that summarized the results of some of the measures that 
they completed as part of participation in the study (see Appendix E). 
Administrations of the C-DISC-IV (including those completed during AD/HD 
Clinic evaluations and as part of this study) were completed by graduate students under 
the supervision of Dr. Arthur Anastopoulos, a licensed psychologist who is certified in 
the administration of the DISC-IV. The student researcher received training in the 
administration of the C-DISC-IV from Dr. Anastopoulos prior to administering this 
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interview to study participants. The student researcher administered the C-DISC-IV for 
all participants who had not previously completed this interview as part of an evaluation 
at the AD/HD Clinic. 
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CHAPTER IV 
RESULTS 
 
 
Preliminary Inspection of the Data 
 An examination of the data revealed that three variables violated the assumption 
of normality: mother BAI score, father BAI score, and father CAARS score. Mother and 
father BAI scores were log transformed, resulting in normally distributed variables. The 
father CAARS score was unable to be transformed due to the severely non-normal 
distribution of this data as well as the small number of fathers participating. Final skew 
statistics for all predictor and outcome variables ranged from -.86 to 1.00; final kurtosis 
statistics for all variables, except father CAARS score, ranged from -1.08 to .40. All data 
to be entered in the regression analyses, except for father CAARS score, fulfilled the 
assumption of normality. 
Description of the Sample 
 Descriptive statistics for the AD/HD status, predictor, and outcome variables 
appear in Table 2. In terms of number of AD/HD symptoms, parents endorsed an average 
of 12.54 total symptoms (SD = 4.33), which is consistent with expectations for a clinical 
sample as a minimum of six symptoms are required for a diagnosis of AD/HD. On the 
ADHD-RS, parents tended to endorse a higher number of symptoms of inattention (M = 
7.18, SD = 2.26) than hyperactivity-impulsivity (M = 5.36, SD = 2.98); a paired-samples 
t-test indicates that this difference is significant (t = 3.15, df = 27, p < .01). Parents also 
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tended to rate their children as more severely inattentive (M = 19.43, SD = 5.29) than 
hyperactive-impulsive (M = 15.39, SD = 7.73); this difference in the severity ratings was 
also significant (t = 3.04, df = 27, p < .05). On the CBRS, parents tended to rate 
inattentive and hyperactive-impulsive symptoms at similar severities (t = 1.75, df = 26, p 
= ns). 
 In terms of the predictor variables, the average mother and father BAI scores were 
within the “not clinically significant” range prior to the log transformations of these 
variables (Mmother = 8.65, SD = 9.24; Mfather = 5.71, SD = 6.92). The average mother and 
father BDI scores were reflective of mild to moderate depression (Mmother = 11.64, SD = 
6.63; Mfather = 8.29, SD = 7.39). The mean t-score for mothers on the CAARS was 47.80 
(SD = 11.79), which is within the normal range; however, the mean t-score for fathers on 
the CAARS was 65.50 (SD = 13.25), which is reflective of a clinically significant 
elevation in symptoms of AD/HD. The mean APQ inconsistent parenting subscale z-
score was -.16 (SD = .96), which is reflective of an average amount of inconsistent 
parenting. The mean PAI raw score was 74.52 (SD = 19.51). 
 In terms of the outcome variables, a wide range of scores was observed on the 
dimensional measures of anxiety (MASC-C and MASC-P). The mean MASC-C t-score 
was 52.21 (SD = 12.60), which is within the normal range, and the mean MASC-P raw 
score was 50.25 (SD = 15.34). However, less variance was observed on the categorical 
outcome variables (C-DISC-IV GAD and SP diagnoses); zero percent of the sample met 
criteria for C-DISC-IV GAD, and only 14.29% (n = 4) of the sample met C-DISC-IV 
criteria for SP. 
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Correlations among Variables 
 Correlations among the variables were conducted and are displayed in Table 3. 
Several correlations were significant. Higher ADHD-RS inattention severity scores were 
associated with higher ADHD-RS hyperactivity-impulsivity severity scores (r = .47, n = 
28, p < .05). Higher ADHD-RS hyperactivity-impulsivity severity scores were also 
associated with increased use of inconsistent parenting strategies on the APQ (r = .60, n = 
28, p < .01). Maternal BAI and BDI scores were correlated (r = .67, n = 26, p < .01), as 
were paternal self-reported anxiety and depression (r = .95, n = 7, p < .01). Older child 
age was associated with higher father BAI scores (r = .78, n = 7, p < .05) and with higher 
father BDI scores (r = .80, n = 7, p < .05). 
 Several correlations also approached significance. Increased child age was 
associated with decreased ADHD-RS inattention severity (r = -.34, n = 28, p = .08). 
Child sex was associated with MASC-C score (r = -.33, n = 28, p = .09), such that 
increased child anxiety was associated with being female. Higher father BDI score was 
associated with MASC-C scores (r = .672, n = 7, p = .10). 
Predicting Child Anxiety 
 Due to the small number of fathers participating in the study and the fact that the 
paternal psychopathology variables were not significantly correlated with the outcome 
variables, only mother BAI, BDI, and CAARS scores were used in the following primary 
analyses. 
To test the first hypothesis that inconsistent parenting practices would be 
associated with anxiety in children with AD/HD, two stepwise regressions were 
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conducted with MASC-C and MASC-P total scores as outcome variables. Child age and 
sex were entered in the first step of the regression as covariates, ADHD-RS inattention 
severity and ADHD-RS hyperactivity-impulsivity severity were entered in the second 
step, and APQ inconsistent parenting and PAI scores were entered in the third step. No 
variables entered into the equation in either of these regressions. A logistic regression 
was also conducted in order to determine whether inconsistent parenting practices 
predicted C-DISC-IV SP diagnosis. C-DISC-IV SP diagnosis was regressed on APQ 
inconsistent parenting and PAI scores; this regression was not significant (χ2 = 3.23, df = 
2, p = ns). 
 To test the second hypothesis that parental symptoms of AD/HD would account 
for unique variance in child anxiety over and above the variance accounted for by 
parental anxiety and depression, two stepwise regressions were conducted with MASC-C 
and MASC-P total scores as outcome variables. Child age and sex were entered in the 
first step of the regression as covariates, ADHD-RS inattention severity and ADHD-RS 
hyperactivity-impulsivity severity were entered in the second step, mother BAI and BDI 
scores were entered in the third step, and mother CAARS scores were entered in the 
fourth step. No variables entered into the equation in either of these regressions. A 
logistic regression was also conducted in order to determine whether maternal 
psychopathology predicted C-DISC-IV SP diagnosis. C-DISC-IV SP diagnosis was 
regressed on mother BAI, BDI, and CAARS scores; the overall model was significant (χ2 
= 12.59, df = 3, p < .01). The regression coefficients for this model can be found in Table 
4. The coefficient for maternal CAARS score approached significance (β = .22, SE = .13, 
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p = .08), indicating that higher maternal symptoms of AD/HD are associated with a child 
diagnosis of SP. 
 In order to test the third hypothesis that locus of control would moderate the 
relation between inconsistent parenting and child anxiety, the APQ, PAI, and NSLOC 
variables were centered. The centered variables were multiplied to create the APQ x 
NSLOC and PAI x NSLOC interaction terms. Stepwise multiple regressions were 
conducted in which the MASC-C and MASC-P variables were regressed on APQ, 
NSLOC, and APQ x NSLOC and on PAI, NSLOC, and PAI x NSLOC. These 
regressions were not significant. Logistic regressions were also conducted in which C-
DISC-IV SP status was also regressed on these parenting predictors. These regressions 
were also not significant. 
Age of Onset for AD/HD and Anxiety Disorders 
 As mentioned previously, only four participants met C-DISC-IV criteria for SP, 
and no participants met C-DISC-IV criteria for GAD. Formal statistical comparisons of 
the age of onset for AD/HD and SP were not appropriate due to the small number of 
participants meeting C-DISC-IV criteria for both disorders. Three parents reported that 
their children’s symptoms of AD/HD and SP had emerged at the same age; the fourth 
parent reported that the symptoms of SP had emerged prior to the symptoms of AD/HD. 
Post-Hoc Analyses 
 Due to the small number of participants that met C-DISC-IV criteria for GAD or 
SP, the C-DISC-IV intermediate diagnoses and symptom counts were used in post-hoc 
analyses. Data for 25 participants were included in these analyses, due to missing data for 
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three participants. Fifty-two percent (n = 13) of participants met C-DISC-IV criteria for a 
full or intermediate diagnosis of SP, and 24.00% (n = 6) of participants met C-DISC-IV 
criteria for a full or intermediate diagnosis of GAD. Logistic regressions were conducted 
in which C-DISC-IV GAD diagnosis (defined as a full or intermediate diagnosis of 
GAD) and C-DISC-IV SP diagnosis (defined as a full or intermediate diagnosis of SP) 
were regressed on the parenting variables and on the maternal psychopathology variables 
(for a total of four logistic regressions). None of these logistic regressions were 
significant. The C-DISC-IV symptom counts for GAD and SP were also examined; for 
GAD, a participant may display between zero and twelve symptoms, and for SP, a 
participant may display between zero and thirteen symptoms. The symptom counts for 
GAD and SP were regressed on the parenting variables and on the maternal 
psychopathology variables (for a total of four logistic regressions). The regression of 
GAD symptoms on the parental psychopathology variables was significant (F = 5.514, df 
= 3, p < .01). None of the other regressions were significant. 
 Post-hoc analyses were conducted in order to determine whether there were 
significant differences between the participants who met C-DISC-IV criteria for both 
AD/HD and SP (AD/HD + SP group) and the other participants (AD/HD only group) 
with regard to the parenting or paternal psychopathology variables. First, the groups were 
compared on child age, sex, ADHD-RS inattention severity, and ADHD-RS 
hyperactivity-impulsivity severity. Participants in these groups did not differ with regard 
to age or ADHD-RS hyperactivity-impulsivity severity. For sex, Levene’s Test for 
equality of variances indicated that the two groups did not have equal variances (F = 
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29.71, p < .01); a t-test for equality of means when equal variances was not assumed 
revealed a significant difference with regard to the sex composition of these two groups (t 
= 3.39, df = 23.00, p < .01). The AD/HD + SP group contained 100% (N = 4) female 
participants, whereas the AD/HD only group contained 33.33% (N = 8) female 
participants. For ADHD-RS inattention severity, Levene’s Test for equality of variances 
indicated that the two groups did not have equal variances (F = 5.76, p < .05); a t-test for 
equality of means when equal variances was not assumed revealed a trend for 
significance with regard to the difference in ADHD-RS inattention severity scores for 
these two groups (t = -1.83, df = 22.59, p < .05). The AD/HD + SP group had more 
severe symptoms of inattention (M = 21.50, SD = 1.29) than the AD/HD only group (M = 
19.08, SD = 5.63), although both of these mean scores are within the clinical range. 
Next, in order to determine whether the AD/HD + SP group and the AD/HD only 
group differed on the parenting and maternal psychopathology variables, t-tests were 
conducted to compare these groups on maternal BAI, BDI and CAARS scores and on 
PAI and APQ inconsistent parenting practices scores. The t-test for maternal BAI score 
approached significance (T = -1.99, df = 24, p = .06) and indicated that mothers of 
children in the AD/HD + SP group reported significantly more symptoms of anxiety than 
mothers of children in the AD/HD only group. The t-test for maternal BDI score was not 
significant. The t-test for maternal CAARS score was significant (T = -3.90, df = 23, p < 
.01) and indicated that mothers of children in the AD/HD + SP group reported 
significantly more symptoms of AD/HD than mothers of children in the AD/HD only 
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group. The t-tests for the APQ inconsistent parenting practices subscale and the PAI were 
not significant. 
Two multivariate multiple regressions were conducted in order to determine 
whether the parenting variables or maternal psychopathology variables were associated 
with MASC-C subscale scores (physical symptoms, harm avoidance, social phobia, and 
separation anxiety/panic). In the first multivariate multiple regression, the MASC-C 
subscale scores were regressed on the PAI and APQ inconsistent parenting practices 
scores; this multivariate multiple regression was not significant. In the second 
multivariate multiple regression, the MASC-C subscale scores were regressed on the 
maternal BAI, BDI, and CAARS scores. There was a trend for significance for maternal 
BAI score to predict the outcome variables (Λ = .653, F = 2.261, df = 4, p = .11). Neither 
maternal BDI score nor maternal CAARS score predicted the MASC-C subscale scores. 
Because these multivariate multiple regressions were not significant, univariate follow-up 
tests were not conducted. 
Because the CBRS provides scores similar to the primary outcome variables of 
this study, additional analyses were conducted in order to determine the utility of these 
scores. In order to explore the association between the parenting variables, the maternal 
psychopathology variables, and the CBRS anxiety scores, correlations between the PAI, 
APQ inconsistent parenting scale, maternal BAI, maternal BDI, and maternal CAARS 
scores, and CBRS GAD, SP, and SAD subscale scores were calculated. There were no 
significant correlations between the parenting variables and the CBRS anxiety subscales. 
Increased maternal anxiety was associated with increased CBRS GAD score (r = .409, n 
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= 26, p < .05) and with increased CBRS SAD score (r = .444, n = 26, p < .05). There was 
a trend for significance for the association between CBRS SAD score and maternal BDI 
score (r = .334, n = 27, p = .09). 
In order to determine whether the parenting variables or maternal 
psychopathology variables were associated with MASC-C scores or CBRS anxiety scores 
indicative of clinically significant anxiety, a series of logistic regressions was conducted. 
First, a new variable was created that indicated whether the MASC-C t-score was greater 
than or equal to 60 (coded as a 1) or less than 60 (coded as a 0). New variables were also 
created that indicated whether the CBRS GAD, SP, and SAD subscale t-scores were 
equal or greater than 65. The creation of these new variables indicated that 26.67% (n = 
8) of the sample had a t-score of greater than 60 on the MASC-C, 81.48% (n = 22) had a 
t-score of greater than 65 on the CBRS GAD subscale, 62.96% (n = 17) had a t-score of 
greater than 65 on the CBRS SP subscale, and 51.85% (n = 14) had a t-score of greater 
than 65 on the CBRS SAD subscale. The logistic regression of the new CBRS SP 
variable on maternal BAI, BDI, and CAARS scores was significant (χ2 = 10.22, df = 3, p 
< .05). The regression coefficients for this regression analysis can be found in Table 5. 
The coefficient for maternal CAARS score approached significance (β = .22, SE = .12, p 
= .06) and indicates that increased maternal symptoms of AD/HD are associated with 
higher parent-reported ratings of child social phobia. None of the other logistic 
regressions were significant. 
In order to explore whether other aspects of parenting were associated with 
anxiety in this sample, the APQ subscales and total score were correlated with the 
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MASC-C and MASC-P total scores. The APQ monitoring subscale was significantly 
correlated with the MASC-C total t-score (r = .527, n = 28, p < .01), indicating that poor 
monitoring/supervision was associated with child anxiety. The APQ total score was also 
significantly correlated with the MASC-C total t-score (r = .416, n = 28, p < .05). 
Multiple regressions, multivariate multiple regressions, and logistic regressions were 
conducted in order to determine whether the APQ monitoring subscale or the APQ total 
score, in combination with the PAI, predicted MASC-C total score, MASC-P total score, 
MASC-C subscale scores, or C-DISC-IV SP diagnosis; none of these regressions were 
significant. 
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CHAPTER V 
DISCUSSION 
 
 
 It is well-documented that children with AD/HD are at increased risk for the 
development of anxiety. Some have estimated that around 25% of children with AD/HD 
have an anxiety disorder (Tannock, 2000), and a large meta-analysis found that children 
with AD/HD have a three times greater risk of developing an anxiety disorder than 
children in the general population (Angold et al., 1999). Although this comorbidity is 
well-documented, the reasons for this overlap are not as well-understood. With regard to 
the timing of AD/HD and anxiety, AD/HD frequently develops first and is followed by 
the onset of anxiety in later development; some have referred to this sequence as a “post-
morbidity” (Taurines, 2010). This developmental sequence suggests that having AD/HD 
may put children at increased risk for having anxiety. Some research has begun to 
identify potential risk factors that may increase the likelihood of developing anxiety in 
children with AD/HD; these potential risk factors have included negative or controlling 
parenting practices, parental psychopathology, child externalizing symptoms, and child 
educational difficulties (Acosta et al., 2008; Baldwin & Dadds, 2008; Kepley & 
Ostrander, 2007; McGee, 2007; Moulton, 2006). 
The purpose of this study was to further examine the role of parenting practices 
and parental psychopathology in predicting anxiety in a sample of children with AD/HD. 
Study hypotheses were guided by a model of anxiety development in children with 
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AD/HD that was informed by Chorpita and Barlow’s (1998) model of anxiety 
development. Specifically, this study hypothesized that inconsistent parenting practices 
and parental psychopathology would predict symptoms of anxiety in children with 
AD/HD. The study also hypothesized that locus of control would moderate the relation 
between parenting practices and anxiety, and that parents would report that their 
children’s symptoms of AD/HD emerged before their symptoms of anxiety. 
Summary of Results 
 Planned analyses revealed initial and tentative support for the role of maternal 
psychopathology as a predictor of child anxiety in this sample of children with AD/HD. 
A logistic regression supported the hypothesis that maternal symptoms of anxiety, 
depression, and AD/HD would predict C-DISC-IV SP diagnosis; the regression 
coefficient for maternal symptoms of AD/HD approached significance, indicating that 
maternal symptoms of AD/HD were most highly associated with C-DISC-IV SP status. 
However, when the C-DISC-IV SP diagnosis was expanded to include a full or 
intermediate C-DISC-IV diagnosis of SP for a post-hoc analysis, the regression of C-
DISC-IV SP on the maternal psychopathology variables was no longer significant. This 
finding points to the instability of these results in this small sample. These maternal 
psychopathology variables did not significantly predict dimensional measures of child 
anxiety. Measures of inter-parent consistency and inconsistent discipline did not 
significantly predict C-DISC-IV SP diagnosis or symptoms of child anxiety. Further, the 
hypothesis regarding the moderating role of child locus of control in the relation between 
inconsistent parenting and child anxiety was not supported. With regard to the hypothesis 
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regarding the ages of onset for AD/HD and anxiety, only a small number (n = 4) met full 
C-DISC-IV criteria for both AD/HD and an anxiety disorder. Of these participants, four 
parents reported that their child’s symptoms of AD/HD and anxiety had emerged at the 
same age, and one parent reported that her child’s symptoms of anxiety had emerged 
before symptoms of AD/HD. 
 A number of post-hoc analyses were conducted in order to further test the a priori 
hypotheses as well as several other possible predictors of child anxiety in this sample. 
Several of these analyses provided additional initial support for the hypothesis that 
maternal psychopathology would predict child anxiety in this sample. A comparison of 
the subset of the sample that met criteria for both AD/HD and SP and those who met 
criteria for AD/HD only indicated that mothers of children in the AD/HD + SP group had 
significantly more symptoms of AD/HD. The maternal psychopathology variables also 
significantly predicted clinically significant symptoms of SP on the CBRS, and the 
regression coefficient for maternal symptoms of AD/HD approached significance. 
Increased maternal anxiety was also significantly correlated with the CBRS GAD score 
and the CBRS SAD score. There was also a trend for significance for maternal 
depression to predict the MASC-C subscale scores (physical symptoms, harm avoidance, 
social anxiety, and separation/panic) in a multivariate multiple regression. There was also 
a trend for maternal depression to predict the CBRS SAD score. The hypothesis that 
inter-parent inconsistency and inconsistent discipline would predict child anxiety in this 
sample was not supported in the post-hoc analyses. However, a different dimension of 
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parenting, decreased parental monitoring and supervision, was found to correlate 
significantly with child-reported symptoms of anxiety.  
 In summary, the findings of this study did not support Hypothesis 1 that 
inconsistent parenting practices would predict child anxiety in children with AD/HD. The 
findings of this study tentatively supported Hypothesis 2 that maternal psychopathology 
would predict child anxiety, and maternal symptoms of AD/HD were significantly 
associated with child anxiety in some, but not all, planned and post-hoc analyses. 
Hypothesis 3, that child locus of control would moderate the relation between 
inconsistent parenting and child anxiety, was not supported. Lastly, Hypothesis 4 that 
parents would report that symptoms of AD/HD emerged before symptoms of anxiety was 
not supported; however, very few participants in this sample met criteria for both AD/HD 
and an anxiety disorder. 
Implications 
 The findings of this study have implications for theory, research, and clinical 
practice. With regard to the theoretical model proposed by this study, the findings 
provided initial support for Hypothesis 2. Overall, the finding that maternal 
psychopathology predicts anxiety in children with AD/HD is consistent with past 
research (Kepley & Ostrander, 2007; McGee, 2007; Moulton, 2006). However, the 
specific finding that maternal symptoms of AD/HD are associated with child anxiety is a 
new contribution to this literature. Parental anxiety and depression have been firmly 
established as correlates of child anxiety in children with and without AD/HD (Flannery-
Schroeder, 2004), but parental AD/HD has not been previously examined as a risk factor 
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for anxiety in children. Considering that AD/HD is conceptualized as having a genetic 
basis (Barkley, 2006a), parental AD/HD may be a particularly salient potential risk factor 
for anxiety in families of children with AD/HD. Inconsistent parenting was not supported 
as a predictor of anxiety in this sample, and this finding has several possible explanations. 
It is possible that children do not perceive inconsistent parenting to be an uncontrollable 
stimulus, that other dimensions of parenting that have been established as correlates of 
child anxiety (such as overprotectiveness or overcontrolling parenting) explain more 
variance in child anxiety, or that this analysis did not have sufficient power to detect the 
effect of inconsistent parenting. 
The results of this study suggest several areas for continued research. First, 
continued research on the role of maternal psychopathology as a predictor of anxiety in 
children with AD/HD is needed; in particular, this research should utilize a larger sample 
of children and attempt to recruit larger numbers of children with clinically-significant 
anxiety. The role of paternal anxiety, depression, and AD/HD as predictors of anxiety in 
children with AD/HD is still unclear; future research should examine whether parental 
psychopathology contributes to an understanding of anxiety in children with AD/HD. It is 
also important to examine the mechanisms by which parental psychopathology may 
influence the development of anxiety in children with AD/HD and to determine whether 
these mechanisms are unique to children with AD/HD and their families or whether these 
mechanisms may generalize to a broader sample of children. In this study, parental 
psychopathology was hypothesized to predict child anxiety through an association with 
inconsistent parenting; however, there was no association between inconsistent parenting 
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and child anxiety in this study. Longitudinal research on the risk factors for anxiety in 
children with AD/HD may be useful in establishing causal links between parental 
psychopathology and anxiety in children with AD/HD, and may also be useful for 
examining potential mechanisms that help to explain the relation between parental 
psychopathology and anxiety in children with AD/HD. 
 The finding that maternal AD/HD predicts anxiety in children with AD/HD, if 
replicated in future research, may have implications for the assessment and treatment of 
children with AD/HD and their families. This finding suggests a more important role for 
parental psychopathology in the assessment, case conceptualization, and treatment 
planning for children with AD/HD; for example, assessment of parental psychopathology 
may be an important part of a comprehensive psychological assessment of a child 
suspected of having AD/HD. Psychosocial treatment of children with AD/HD frequently 
involves parent training; this finding suggests that acknowledging or addressing parental 
psychopathology during such parent training may enhance the ability of parent training to 
help protect children with AD/HD against anxiety or possibly other comorbid disorders. 
Family interventions for children and parents that both have anxiety have been shown to 
be effective (Cobham, Dadds, & Spence, 1998), but similar interventions have yet to be 
developed for children and parents that both have AD/HD. If further research establishes 
a mechanism by which parental psychopathology influences the development of anxiety 
in children with AD/HD, it may also be important to address those factors clinically. 
 Lastly, this study used several measures of child anxiety and raises issues about 
the utility of the MASC, the CBRS anxiety subscales, and the C-DISC-IV in this 
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population. For example, a comparison of the rates of clinically significant anxiety 
obtained by using each measure varied widely: 26.67% (n = 8) of the sample had a t-
score of greater than 60 on the MASC-C, 81.48% (n = 22) had a t-score of greater than 65 
on the CBRS GAD subscale, 62.96% (n = 17) had a t-score of greater than 65 on the 
CBRS SP subscale, 51.85% (n = 14) had a t-score of greater than 65 on the CBRS SAD 
subscale, and 14.29% (n = 4) met C-DISC-IV SP criteria.  Past research has demonstrated 
that there is only moderate agreement between parents and children regarding children’s 
symptoms of anxiety (Greco & Morris, 2004), and the varying rates of clinically-
significant anxiety obtained by each measure in this study is consistent with this past 
finding. For example, the child self-reported anxiety on the MASC-C was lower than the 
parent-reported child anxiety on the CBRS. However, even with regard to the two parent-
reported measures, the CBRS and the C-DISC-IV, the rates of clinically significant 
anxiety reported varied widely. This finding suggests the importance of future research 
on the utility of the MASC (particularly the MASC-P), CBRS, and C-DISC-IV in the 
assessment of anxiety and also underscores the importance of a multi-informant, multi-
measure assessment of child psychopathology. 
Limitations 
 Although the results of this study are useful in beginning to understand the role of 
parental psychopathology as a predictor of anxiety in children with AD/HD, these 
findings must be interpreted in the context of the limitations of the study. One important 
limitation of this study was the cross-sectional design. While a longitudinal design would 
have been useful in establishing the temporal relationship between symptoms of AD/HD, 
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parental psychopathology and parenting practices, and child anxiety, a cross-sectional 
design was most practical for the purposes of the current study. The correlational and 
regression analyses employed in this study do not establish causality, but do help to 
elucidate the associations between parental psychopathology, parenting practices, and 
anxiety symptoms in children with AD/HD. 
A second limitation of this study was the small sample size, which impacted 
several of the analyses. The small sample size decreased the power of the study and may 
have impacted the ability to detect small or medium effects in this sample; it is possible 
that the hypotheses regarding inconsistent parenting and age of onset were not supported 
because there was not sufficient power to test these hypotheses. Further, the hypothesis 
that maternal psychopathology predicted child anxiety was supported in some but not all 
of the analyses. For instance, the logistic regression of C-DISC-IV SP full diagnosis on 
maternal psychopathology was significant, but the logistic regression of C-DISC-IV SP 
diagnosis (expanded to also include intermediate diagnoses) was not significant. This 
inconsistency calls the significant result into question, since the first logistic regression 
described had a very uneven distribution of participants in the two outcome 
classifications and the second logistic regression had a more even distribution of 
participants in the two outcome classifications. Further research using a larger sample 
size and in samples containing adequate numbers of participants with clinically-
significant anxiety is needed. 
 A third limitation of this study was that the rate of anxiety reported in this sample, 
both on the MASC-C and the C-DISC-IV, were lower than would be expected based on 
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the reports in the literature (Tannock, 2000). It is uncertain why the rates of anxiety 
reported by participants in this study were lower than was expected. One possible 
explanation is that the majority (82.1%; n = 23) of participants in the project were taking 
at least one medication for the management of AD/HD symptoms. Some initial research 
has found that treatment with stimulant medication may serve as a protective factor 
against anxiety, depression, and disruptive behavior over time in children with AD/HD 
(Biederman, Monuteaux, Spencer, Wilens, & Faraone, 2009). Although it was not 
tracked formally, several parents also indicated on the C-DISC-IV that their child was 
receiving some form of psychosocial treatment for AD/HD or other difficulties. The high 
rate of medication treatment and the utilization of psychosocial treatment by some 
participants may have contributed to the lower-than-expected rates of anxiety. 
Conclusion 
 Overall, this study provided initial support for the role of maternal 
psychopathology as a predictor of anxiety in children with AD/HD. In particular, higher 
maternal symptoms of AD/HD appear to be associated with child anxiety in children with 
AD/HD; parental symptoms of AD/HD were previously unexplored as a possible risk 
factor for anxiety. This finding has implications for the assessment and treatment of 
children with AD/HD. Further research should examine the possible mechanism by 
which maternal psychopathology may influence the development of anxiety in children 
with AD/HD. 
 
50 
 
REFERENCES 
 
 
Abidin, R. R., & Brunner, J. F. (1995). Development of a Parenting Alliance Inventory. 
Journal of Clinical Child Psychology, 24, 31-40. 
Acosta, M. T., Castellanos, F. X., Bolton, K. L., Balog, J. Z., Eagen, P., Nee, L., et al. 
(2008). Latent class subtyping of attention-deficit/hyperactivity disorder and 
comorbid conditions. Journal of the American Academy of Child & Adolescent 
Psychiatry, 47, 797-807. 
American Psychological Association (2000). Diagnostic and Statistical Manual of 
Mental Disorders-Fourth Edition-Text Revision (Vol. 4). Washington, D.C.: 
American Psychiatric Publishing, Inc. 
Anderson, D. J., Noyes, R., & Crowe, R. R. (1984). A comparison of panic disorder and 
generalized anxiety disorder. The American Journal of Psychiatry, 141, 572-575. 
Angold, A., Costello, E. J., & Erkanli, A. (1999). Comorbidity. Journal of Child 
Psychology and Psychiatry, 40, 57-87. 
Baldwin, J. S., & Dadds, M. R. (2007). Reliability and validity of parent and child 
versions of the Multidimensional Anxiety Scale for Children in community 
samples. Journal of the American Academy of Child & Adolescent Psychiatry, 46, 
252-260. 
Baldwin, J. S., & Dadds, M. R. (2008). Examining alternative explanations of the 
covariation of ADHD and anxiety symptoms in children: A community study. 
 
51 
 
Journal of Abnormal Child Psychology, 36, 67-79.Barkley, R. A. (2006). ADHD 
in Adults. In R. A. Barkley (Ed.), Attention-Deficit Hyperactivity Disorder (pp. 
248-296). New York: The Guilford Press. 
Barkley, R. A. (2006a). Etiologies. In R. A. Barkley (Ed.), Attention-Deficit 
Hyperactivity Disorder (pp. 219-247). New York: The Guilford Press. 
Barkley, R. A. (2006b). Primary symptoms, diagnostic criteria, prevalence, and gender 
differences. In R. A. Barkley (Ed.), Attention-Deficit Hyperactivity Disorder (pp. 
76-121). New York: The Guilford Press. 
Barkley, R. A., Fischer, M., Edelbrock, C. S., & Smallish, L. (1990). The adolescent 
outcome of hyperactive children diagnosed by research criteria: I. An 8-year 
prospective follow-up study. Journal of the American Academy of Child & 
Adolescent Psychiatry, 29, 546-557. 
Bayer, J. K., Sanson, A. V., & Hemphill, S. A. (2006). Parent influences on early 
childhood internalizing difficulties. Journal of Applied Developmental 
Psychology, 27, 542-559. 
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring 
clinical anxiety: Psychometric properties. Journal of Consulting and Clinical 
Psychology, 56, 893-897. 
Beck, A. T., Steer, R. A., & Garbin, M. G. (1988). Psychometric properties of the Beck 
Depression Inventory: Twenty-five years of evaluation. Clinical Psychology 
Review, 8, 77-100. 
 
52 
 
Beidel, D. C., & Turner, S. M. (2005). Childhood anxiety disorders: A guide to research 
and treatment. New York: Routledge. 
Biederman, J., Faraone, S. V., Keenan, K., Steingard, R., & Tsuang, M. T. (1991). 
Familial association between attention deficit disorder and anxiety disorders. 
American Journal of Psychiatry, 148, 251-256. 
Biederman, J., Monuteaux, M. C., Mick, E., Spencer, T., Wilens, T. E., Klein, K. L., …  
Faraone, S. V. (2006). Psychopathology in females with attention-
deficit/hyperactivity disorder: A controlled, five-year prospective study. 
Biological Psychiatry, 60, 1098-1105. 
Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., & Faraone, S. V. (2009). 
Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-
year follow-up study. Pediatrics, 124, 71-78. 
Biederman, J., Petty, C., Monuteaux, M., Fried, R., Byrne, D., Mirto, T., … Faraone, S. 
(2010). Adult psychiatric outcomes of girls with attention deficit hyperactivity 
disorder: 11-Year follow-up in a longitudinal case-control study. The American 
Journal of Psychiatry, 167, 409-417. 
Borden, J. W., Peterson, D. R., & Jackson, E. A. (1991). The Beck Anxiety Inventory in 
nonclinical samples: Initial psychometric properties. Journal of Psychopathology 
and Behavioral Assessment, 13, 345-356. 
Braaten, E. B., Beiderman, J., Monuteaux, M. C., Mick, E., Calhoun, E., Cattan, G., & 
Faraone, S. V. (2003). Revisiting the association between attention-
 
53 
 
deficit/hyperactivity disorder and anxiety disorders: a familial risk analysis. 
Biological Psychiatry, 53, 93-99. 
Bradley, J. D. D., & Golden, C. J. (2001). Biological contributions to the presentation and 
understanding of attention-deficit/hyperactivity disorder: A review. Clinical 
Psychology Review, 21, 907-929. 
Bussing, R., Mason, D. M., Bell, L., Porter, P., & Garvan, C. (2010). Adolescent 
outcomes of childhood attention-deficit/hyperactivity disorder in a diverse 
community sample. Journal of the American Academy of Child & Adolescent 
Psychiatry, 49, 595-605. 
Campbell, L. A., Brown, T. A., & Grisham, J. R. (2003). The relevance of age of onset to 
the psychopathology of generalized anxiety disorder. Behavior Therapy, 34, 31-
48. 
Choate-Summers, M. L. (2006). The role of control in anxiety in children and 
adolescents. Dissertation Abstracts International: Section B. The Sciences and 
Engineering, 67(1-B), 534. 
Chorpita, B. F., & Barlow, D. H. (1998). The development of anxiety: The role of control 
in the early environment. Psychological Bulletin, 124, 3-21. 
Chronis-Tuscano, A., Raggi, V. L., Clarke, T. L., Rooney, M. E., Diaz, Y., & Pian, J. 
(2008). Associations between maternal attention-deficit/hyperactivity disorder 
symptoms and parenting. Journal of Abnormal Child Psychology, 36, 1237-1250. 
 
54 
 
Cobham, V. E., Dadds, M. R., & Spence, S. H. (1998). The role of parental anxiety in the 
treatment of childhood anxiety. Journal of Consulting and Clinical Psychology, 
66, 893-905. 
Conners, C. K. (2008). Conners Comprehensive Behavior Rating Scales: Multi-Health 
Systems. 
Conners, C. K., Erhardt, D., Epstein, J. N., Parker, J. D. A., Sitarenios, G., & Sparrow, E. 
(1999). Self-ratings of ADHD symptoms in adults: I. Factor structure and 
normative data. Journal of Attention Disorders, 3, 141-151. 
Costello, E. J., Egger, H. L., & Angold, A. (2005). The developmental epidemiology of 
anxiety disorders: Phenomenology, prevalence, and comorbidity. Child and 
Adolescent Psychiatric Clinics of North America, 14, 631-648. 
Costello, E. J., Egger, H. L., & Angold, A. (2004). Developmental epidemiology of 
anxiety disorders. In T. H. Ollendick & J. S. March (Eds.), Phobic and anxiety 
disorders in children and adolescents: A clinician's guide to effective 
psychosocial and pharmacological interventions (pp. 61-91). New York: Oxford 
University Press. 
Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G., & Angold, A. (2003). Prevalence and 
development of psychiatric disorders in childhood and adolescence. Archives of 
General Psychiatry, 60, 837-844. 
DuPaul, G. J., Anastopoulos, A. D., Power, T. J., Reid, R., Ikeda, M. J., & McGoey, K. 
E. (1998). Parent ratings of attention-deficit/hyperactivity disorder symptoms: 
 
55 
 
Factor structure and normative data. Journal of Psychopathology and Behavioral 
Assessment, 20, 83-102. 
Ehringer, M. A., Rhee, S. H., Young, S., Corley, R., & Hewitt, J. K. (2006). Genetic and 
environmental contributions to common psychopathologies of childhood and 
adolescence: A study of twins and their siblings. Journal of Abnormal Child 
Psychology, 34, 1-17. 
Elia, J., Ambrosini, P., & Berrettini, W. (2008). ADHD characteristics: I. Concurrent co-
morbidity patterns in children & adolescents. Child and Adolescent Psychiatry 
and Mental Health, 2. 
Ellis, B., & Nigg, J. (2009). Parenting practices and attention-deficit/hyperactivity 
disorder: New findings suggest partial specificity of effects. Journal of the 
American Academy of Child & Adolescent Psychiatry, 48, 146-154. 
Erhardt, D., Epstein, J. N., Conners, C. K., Parker, J. D. A., & Sitarenios, G. (1999). Self-
ratings of ADHD symptoms in adults: II. Reliability, validity, and diagnostic 
sensitivity. Journal of Attention Disorders, 3, 153-158. 
Flannery-Schroeder, E. S. (2004). Generalized Anxiety Disorder. In T. L. Morris & J. S. 
March (Eds.), Anxiety disorders in children and adolescents (pp. 125-140). New 
York: The Guilford Press. 
Frazier, T. W., Demaree, H. A., & Youngstrom, E. A. (2004). Meta-analysis of 
intellectual and neuropsychological test performance in attention-
deficit/hyperactivity disorder. Neuropsychology, 18, 543-555. 
 
56 
 
Gerdes, A. C., & Hoza, B. (2006). Maternal attributions, affect, and parenting in attention 
deficit hyperactivity disorder and comparison families. Journal of Clinical Child 
and Adolescent Psychology, 35, 346-355. 
Goode, V. (2002). A meta-analysis of the relationship between parenting attributes and 
disruptive behavior in children with ADHD. Dissertation Abstracts International: 
Section B. Sciences and Engingeering, 63(1-B), 587. 
Greco, L. A. & Morris, T. L. (2004). Assessment. In T. L. Morris & J. S. March (Eds.), 
Anxiety Disorders in Children and Adolescents (pp. 98-121). New York: The 
Guilford Press. 
Hammerness, P., Harpold, T., Petty, C., Menard, C., Zar-Kessler, C., & Biederman, J. 
(2008). Characterizing non-OCD anxiety disorders in psychiatrically referred 
children and adolescents. Journal of Affective Disorders, 105, 213-219. 
Heider, D., Matschinger, H., Bernert, S., Alonso, J., Brugha, T. S., Bruffaerts, R., ... 
Angermeyer, M. C. (2008). Adverse parenting as a risk factor in the occurrence of 
anxiety disorders: A study in six European countries. Social Psychiatry and 
Psychiatric Epidemiology, 43, 266-272. 
Hirshfeld, D. R., Rosenbaum, J. F., Biederman, J., & Bolduc, E. A. (1992). Stable 
behavioral inhibition and its association with anxiety disorder. Journal of the 
American Academy of Child & Adolescent Psychiatry, 31, 103-111. 
Jensen, P. S., Martin, D., & Cantwell, D. P. (1997). Comorbidity in ADHD: Implications 
for research, practice, and DSM-V. Journal of the American Academy of Child & 
Adolescent Psychiatry, 36, 1065-1079. 
 
57 
 
Jensen, P. S., Shervette, R. E., Xenakis, S. N., & Richters, J. (1993). Anxiety and 
depressive disorders in attention deficit disorder with hyperactivity: New findings. 
American Journal of Psychiatry, 150, 1203-1209. 
Kaplan, M. H., & Feinstein, A. R. (1974). The importance of classifying initial co-
morbidity in evaluating the outcome of diabetes mellitus. Journal of Chronic 
Diseases, 27, 387-404. 
Kendall, P. C., Compton, S. N., Walkup, J. T., Birmaher, B., Albano, A. M., Sherrill, J., 
… Piacentini, J. (2010). Clinical characteristics of anxiety disordered youth. 
Journal of Anxiety Disorders, 24, 360-365. 
Kepley, H. O., & Ostrander, R. (2007). Family characteristics of anxious ADHD 
children: Preliminary results. Journal of Attention Disorders, 10, 317-323. 
Last, C. G., Hersen, M., Kazdin, A. E., & Finkelstein, R. (1987). Comparison of DSM-III 
separation anxiety and overanxious disorders: Demographic characteristics and 
patterns of comorbidity. Journal of the American Academy of Child & Adolescent 
Psychiatry, 26, 527-531. 
Last, C. G., Perrin, S., Hersen, M., & Kazdin, A. E. (1992). DSM-III--R anxiety disorders 
in children: Sociodemographic and clinical characteristics. Journal of the 
American Academy of Child & Adolescent Psychiatry, 31, 1070-1076. 
Lavigne, J. V., LeBailly, S. A., Hopkins, J., Gouze, K. R., & Binns, H. J. (2009). The 
prevalence of ADHD, ODD, depression, and anxiety in a community sample of 4-
year-olds. Journal of Clinical Child and Adolescent Psychology, 38, 315-328. 
 
58 
 
Lewinsohn, P. M., Gotlib, I. H., Lewinsohn, M., Seeley, J. R., & Allen, N. B. (1998). 
Gender differences in anxiety disorders and anxiety symptoms in adolescents. 
Journal of Abnormal Psychology, 107, 109-117. 
Lilienfeld, S. O. (2003). Comorbidity between and within childhood externalizing and 
internalizing disorders: Reflections and directions. Journal of Abnormal Child 
Psychology, 31, 285-291. 
Lilienfeld, S. O., Waldman, I. D., & Israel, A. C. (1994). A critical examination of the 
use of the term and concept of comorbidity in psychopathology research. Clinical 
Psychology: Science and Practice, 1, 71-83. 
Manassis, K., Hudson, J. L., Webb, A., & Albano, A. M. (2004). Beyond behavioral 
inhibition: Etiological factors in childhood anxiety. Cognitive and Behavioral 
Practice, 11, 3-12. 
March, J. S., Conners, C., Arnold, G., Epstein, J., Parker, J., Hinshaw, S., et al. (1999). 
The Multidimensional Anxiety Scale for Children (MASC): Confirmatory factor 
analysis in a pediatric ADHD sample. Journal of Attention Disorders, 3, 85-89. 
March, J. S., Parker, J. D. A., Sullivan, K., & Stallings, P. (1997). The Multidimensional 
Anxiety Scale for Children (MASC): Factor structure, reliability, and validity. 
Journal of the American Academy of Child & Adolescent Psychiatry, 36, 554-565. 
March, J. S., Swanson, J. M., Arnold, L. E., Hoza, B., Conners, C. K., Hinshaw, S. P., ... 
Pelham, W. E. (2000). Anxiety as a predictor and outcome variable in the 
Multimodal Treatment Study of Children with ADHD (MTA). Journal of 
Abnormal Child Psychology, 28, 527-541. 
 
59 
 
Marks, I. M. (1986). Genetics of fear and anxiety disorders. British Journal of 
Psychiatry, 149, 406-418. 
Massion, A. O., Warshaw, M. G., & Keller, M. B. (1993). Quality of life and psychiatric 
morbidity in panic disorder and generalized anxiety disorder. The American 
Journal of Psychiatry, 150, 600-607. 
McGee, E. H. (2007). Factors associated with the development of anxiety among children 
with Attention-Deficit/Hyperactivity Disorder. Unpublished dissertation. The 
University of North Carolina at Greensboro. 
McLeod, B. D., Wood, J. J., & Weisz, J. R. (2007). Examining the association between 
parenting and childhood anxiety: A meta-analysis. Clinical Psychology Review, 
27, 155-172. 
Moulton, C. E. (2006). Parenting predictors of anxiety in children with attention deficit 
hyperactivity disorder. Dissertation Abstracts International Section A: 
Humanities and Social Sciences, 66(10-A), 3567. 
Murray, C., & Johnston, C. (2006). Parenting in mothers with and without attention-
deficit/ hyperactivity disorder. Journal of Abnormal Psychology, 115, 52-61. 
Nixon, E. (2001). The social competence of children with attention deficit hyperactivity 
disorder: A review of the literature. Child and Adolescent Mental Health, 6, 172-
180. 
Nowicki, S., & Strickland, B. R. (1973). A locus of control scale for children. Journal of 
Consulting and Clinical Psychology, 40, 148-154. 
 
60 
 
Noyes, R., Woodman, C., Garvey, M. J., & Cook, B. L. (1992). Generalized anxiety 
disorder vs. panic disorder: Distinguishing characteristics and patterns of 
comorbidity. Journal of Nervous and Mental Disease, 180, 369-379. 
Perrin, S., & Last, C. G. (1996). Relationship between ADHD and anxiety in boys: 
Results from a family study. Journal of the American Academy of Child & 
Adolescent Psychiatry, 35, 988-996. 
Pfiffner, L. J., & McBurnett, K. (2006). Family correlates of comorbid anxiety disorders 
in children with attention deficit/hyperactivity disorder. Journal of Abnormal 
Child Psychology, 34, 725-735. 
Piotrowski, N. A. (2007). Comorbidity and psychological science: Does one size fit all? 
Clinical Psychology: Science and Practice, 14, 6-19. 
Piper, S. S. (2007). Comorbidity of attention-deficit/hyperactivity disorder and 
internalizing disorders in children and adolescents: Neuropsychological profiles. 
Dissertation Abstracts International: Section B. The Sciences and Engineering, 
67(8-B), 4720. 
Pliszka, S. R., McCracken, J. T., & Maas, J. W. (1996). Catecholamines in attention-
deficit hyperactivity disorder: Current perspectives. Journal of the American 
Academy of Child & Adolescent Psychiatry, 35, 264-272. 
Psychogiou, L., Daley, D. M., Thompson, M. J., & Sonuga-Barke, E. J. S. (2008). Do 
maternal attention-deficit/hyperactivity disorder symptoms exacerbate or 
ameliorate the negative effect of child attention-deficit/hyperactivity disorder 
symptoms on parenting? Development and Psychopathology, 20, 121-137. 
 
61 
 
Robinson, J. L., Kagan, J., Reznick, J. S., & Corley, R. (1992). The heritability of 
inhibited and uninhibited behavior: A twin study. Developmental Psychology, 28, 
1030-1037. 
Rommelse, N. N. J., Altink, M. E., Fliers, E. A., Martin, N. C., Buschgens, C. J. M., 
Hartman, C. A., et al. (2009). Comorbid problems in ADHD: Degree of 
association, shared endophenotypes, and formation of distinct subtypes. 
Implications for a future DSM. Journal of Abnormal Child Psychology, 37, 793-
804. 
Rosenbaum, J. F., Biederman, J., Bolduc-Murphy, E. A., & Faraone, S. V. (1993). 
Behavioral inhibition in childhood: A risk factor for anxiety disorders. Harvard 
Review of Psychiatry, 1, 2-16. 
Shaffer, D., Fisher, P., Dulcan, M. K., & Davies, M. (1996). The NIMH Diagnostic 
Interview Schedule for Children Version 2.3 (DISC-2.3): Description, 
acceptability, prevalence rates, and performance in the MECA study. Journal of 
the American Academy of Child & Adolescent Psychiatry, 35, 865-877. 
Shaffer, D., Fisher, P., Lucas, C. P., Dulcan, M. K., & Schwab-Stone, M. E. (2000). 
NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): 
Description, differences from previous versions, and reliability of some common 
diagnoses. Journal of the American Academy of Child & Adolescent Psychiatry, 
39, 28-38. 
 
62 
 
Shelton, K. K., Frick, P. J., & Wootton, J. (1996). Assessment of parenting practices in 
families of elementary school-age children. Journal of Clinical Child Psychology, 
25, 317-329. 
Silva, M., Dorso, E., Azhar, A., & Renk, K. (2007). The relationship among parenting 
styles experienced during childhood, anxiety, motivation, and academic success in 
college students. Journal of College Student Retention: Research, Theory and 
Practice, 9, 149-167. 
Stein, M. A., Szumowski, E., Blondis, T. A., & Roizen, N. J. (1995). Adaptive skills 
dysfunction in ADD and ADHD children. Journal of Child Psychology and 
Psychiatry, 36, 663-670. 
Tannock, R. (2000). Attention-deficit/hyperactivity disorder with anxiety disorders. In T. 
Brown (Ed.), Attention-deficit disorders and comorbidities in children, 
adolescents, and adults (pp. 125-170). Arlington, VA: American Psychiatric 
Publishing, Inc. 
Taurines, R., Schmitt, J., Renner, T., Conner, A. C., Warnke, A., & Romanos, M. (2010). 
Developmental comorbidity in attention-deficit/hyperactivity disorder. Attention 
Deficit Hyperactivity Disorder, 2, 267-289. 
Tracey, S. A., Chorpita, B. F., Douban, J., & Barlow, D. H. (1997). Empirical evaluation 
of DSM-IV generalized anxiety disorder criteria in children and adolescents. 
Journal of Clinical Child Psychology, 26, 404-414. 
Vance, A., Costin, J., Barnett, R., Luk, E., Maruff, P., & Tonge, B. (2002). 
Characteristics of parent- and child-reported anxiety in psychostimulant 
 
63 
 
medication naïve, clincally referred children with attention deficit hyperactivity 
disorder, combined type (ADHD-CT). Australian and New Zealand Journal of 
Psychiatry, 36, 234-239. 
Warren, S. L. & Sroufe, L. A. (2004). Developmental issues. In T. H. Ollendick & J. S. 
March (Eds.), Phobic and anxiety disorders in children and adolescents: A 
clinician's guide to effective psychosocial and pharmacological interventions (pp. 
92-115). New York: Oxford University Press. 
Weems, C. F., Silverman, W. K., & La Greca, A. M. (2000). What do youth referred for 
anxiety problems worry about? Worry and its relation to anxiety and anxiety 
disorders in children and adolescents. Journal of Abnormal Child Psychology, 28, 
63-72. 
Woodman, C. L., Noyes, R., Jr., Black, D. W., Schlosser, S., & Yagla, S. J. (1999). A 5-
year follow-up study of generalized anxiety disorder and panic disorder. Journal 
of Nervous and Mental Disease, 187, 3-9. 
  
 
64 
 
APPENDIX A: CONSENT TO ACT AS A HUMAN PARTICIPANT 
 
UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
 
CONSENT TO ACT AS A HUMAN PARTICIPANT 
 
Project Title:  Risk Factors for Anxiety in Children with AD/HD 
 
Project Director:  Sarah O’Rourke 
 
Participant's Name:  ______________________________ 
 
What is the study about?  
 
This is a research project. The aim of this research project is to learn why some children 
with Attention-Deficit/Hyperactivity Disorder (AD/HD) also have symptoms of anxiety. 
 
Why are you asking me? 
 
You are invited to participate in this project because you have a child who is between the 
ages of 8 and 15 years old and has AD/HD. 
 
What will you ask me to do if I agree to be in the study? 
 
If you agree to be in this study, you will be asked to complete several questionnaires 
about your child’s symptoms of AD/HD and anxiety. You will also be asked to complete 
questionnaires about being a parent and about your own symptoms of AD/HD, anxiety, 
and depression. You will be asked to complete an interview about your child’s symptoms 
of AD/HD and anxiety. It will take one to two hours to complete the study visit. 
Completion of the interview or questionnaires may make you feel uncomfortable. If you 
have any questions about the study procedures, you may contact the Project Director, 
Sarah O’Rourke, at (336) 346-3196 x. 704. 
 
What are the dangers to me? 
 
There is minimal risk associated with being in this study. The questionnaires and 
diagnostic interview ask about personal information, such as symptoms of AD/HD and 
anxiety. Answering these questions may make you feel uncomfortable. You may skip 
questions that you do not want to answer. Participation is completely voluntary. 
 
If you have any concerns about your rights, how you are being treated or if you have 
questions, want more information or have suggestions, please contact Eric Allen in the 
Office of Research Compliance at UNCG at (336) 256-1482.Questions, concerns or 
complaints about this project or benefits or risks associated with being in this study can 
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be answered by Sarah O’Rourke who may be contacted at (336) 346-3196 x. 704 or Dr. 
Arthur D. Anastopoulos who may be contacted at (336) 346-3196 x. 303. 
 
Are there any benefits to me for taking part in this research study? 
 
You will receive a summary of the measures that you and your child completed. This 
summary is intended as a summary of research data. It is not a tool for making decisions 
about your or your child’s mental health care. However, this summary information may 
be of some use to clinicians working with you or your child. 
 
Are there any benefits to society as a result of me taking part in this research? 
 
Increased knowledge about why some children with AD/HD also have anxiety may lead 
to improved treatments for children with AD/HD and their families. 
 
Will I get paid for being in the study? Will it cost me anything? 
 
If you and your child participate in this study, you will receive a $10 gift card as payment 
for your time. You will receive a $10 gift card even if you or your child discontinue your 
participation in the study or do not answer certain questions on the questionnaires or 
interview. There are no costs to you or your child for being in this study. 
 
How will you keep my information confidential? 
 
The information that you provide as part of this research study will be kept confidential. 
Your name will not be written on any of the questionnaires that you and your child 
complete. You and your child will be assigned a unique code, and this code will be used 
to identify you. Only the principal investigator and project director will have access to the 
key that links your name with your unique code. The questionnaires that you and your 
child complete will be stored in a locked file cabinet. Passwords will protect information 
that has been entered on the computer. You will not be identified by name when data 
from this project is published. All information obtained in this study is strictly 
confidential unless disclosure is required by law. The investigators are legally required to 
report incidence of child abuse, disabled adult abuse, gunshot/knife wounds, 
communicable diseases, and if you present an imminent danger to the health or safety of 
another or yourself. 
 
During or after your involvement in this research project, you may become aware of 
other research projects being conducted in the AD/HD Clinic that may be of interest to 
you. One such project currently underway is Assessing Problematic Behaviors and 
Emotional Reactions in Adolescents. This study uses some of the same behavioral data 
collection procedures. Should you decide to participate in this other project, behavioral 
data collected from this project can be shared with the other research project in order to 
spare you the trouble of having to repeat the same data gathering procedures. Only the 
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behavioral data common to each project will be shared, and data will only be shared with 
projects for which you have given written consent. 
 
What if I want to leave the study? 
 
You have the right to refuse to participate or to withdraw at any time, without penalty. If 
you do withdraw, it will not affect you in any way. If you choose to withdraw, you may 
request that any of your data that has been collected be destroyed unless it is in a de-
identifiable state. 
 
What about new information/changes in the study? 
 
If significant new information relating to the study becomes available which may relate 
to your willingness to continue to participate, this information will be provided to you. 
 
Voluntary Consent by Participant: 
 
By signing this consent form you are agreeing that you read, or it has been read to you, 
and you fully understand the contents of this document and are openly willing consent to 
take part in this study. All of your questions concerning this study have been answered. 
By signing this form, you are agreeing that you are 18 years of age or older and are 
agreeing to participate, or have the individual specified above as a participant participate, 
in this study described to you bySarah O’Rourke. 
 
 
Signature: ________________________ Date: ________________ 
 
 
It would be ok to contact me in the future about similar research projects (please check 
one):  
☐ Yes  ☐ No 
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APPENDIX B: CONSENT FOR A MINOR TO ACT AS A HUMAN PARTICIPANT 
 
UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
 
CONSENT FOR A MINOR TO ACT AS A HUMAN PARTICIPANT 
 
Project Title:  Risk Factors for Anxiety in Children with AD/HD 
 
Project Director:  Sarah O’Rourke 
 
Participant's Name:  ______________________________ 
 
What is the study about?  
 
This is a research project. The aim of this research project is to learn why some children 
with Attention-Deficit/Hyperactivity Disorder (AD/HD) also have symptoms of anxiety. 
 
Why are you asking my child? 
 
Your child is invited to participate in this project because he or she is between the ages of 
8 and 15 years old and has AD/HD. 
 
What will you ask my child to do if I agree to let him or her be in the study? 
 
If you agree to allow your child to participate in the study, he or she will be asked to 
complete two questionnaires. It will take less than one hour for your child to complete 
these questionnaires. Completion of the study procedures may cause mild discomfort. If 
you have any questions about the study procedures, you may contact the Project Director, 
Sarah O’Rourke, at (336) 346-3196 x. 704. 
 
What are the dangers to my child? 
 
There is minimal risk associated with being in this study. The questionnaires and 
diagnostic interview ask about personal information, such as symptoms of AD/HD and 
anxiety. Answering these questions may make you or your child feel uncomfortable. You 
or your child may skip questions that you do not want to answer. Participation is 
completely voluntary. Even if you participate and give permission for your child to 
participate, your child will still be asked if they want to participate in the project and his 
or her choice will be respected. 
 
If you have any concerns about your rights, how you are being treated or if you have 
questions, want more information or have suggestions, please contact Eric Allen in the 
Office of Research Compliance at UNCG at (336) 256-1482.Questions, concerns or 
complaints about this project or benefits or risks associated with being in this study can 
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be answered by Sarah O’Rourke who may be contacted at (336) 346-3196 x. 704 or Dr. 
Arthur D. Anastopoulos who may be contacted at (336) 346-3196 x. 303. 
 
Are there any benefits to my child as a result of participation in this research study? 
 
You will receive a summary of the measures that you and your child completed. This 
summary is intended as a summary of research data. It is not a tool for making decisions 
about your or your child’s mental health care. However, this summary information may 
be of some use to clinicians working with you or your child. 
 
Are there any benefits to society as a result of my child taking part in this research? 
 
Increased knowledge about why some children with AD/HD also have anxiety may lead 
to improved treatments for children with AD/HD and their families. 
 
Will my child get paid for being in the study?  Will it cost me anything for my kid to 
be in this study? 
 
If you and your child participate in this study, you will receive a $10 gift card as payment 
for your time. You will receive a $10 gift card even if you or your child discontinue your 
participation in the study or do not answer certain questions on the questionnaires or 
interview. There are no costs to you or your child for being in this study. 
 
How will my child’s information be kept confidential? 
 
The information that you and your child provide as part of this research study will be kept 
confidential. Your name will not be written on any of the questionnaires that you and 
your child complete. You and your child will be assigned a unique code, and this code 
will be used to identify you. Only the principal investigator and project director will have 
access to the key that links your name with your unique code. The questionnaires that you 
and your child complete will be stored in a locked file cabinet. Passwords will protect 
information that has been entered on the computer. You will not be identified by name 
when data from this project is published. All information obtained in this study is strictly 
confidential unless disclosure is required by law. The investigator is legally required to 
report incidence of child abuse, disabled adult abuse, gunshot/knife wounds, 
communicable diseases, and if your child presents an imminent danger to the health or 
safety of another or himself/herself. 
 
During or after your involvement in this research project, you may become aware of 
other research projects being conducted in the AD/HD Clinic that may be of interest to 
you. One such project currently underway is Assessing Problematic Behaviors and 
Emotional Reactions in Adolescents. This study uses some of the same behavioral data 
collection procedures. Should you decide to participate in this other project, behavioral 
data collected from this project can be shared with the other research project in order to 
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spare you the trouble of having to repeat the same data gathering procedures. Only the 
behavioral data common to each project will be shared, and data will only be shared with 
projects for which you have given written consent. 
 
What if my child wants to leave the study or I want him/her to leave the study? 
 
You have the right to refuse to allow your child to participate or to withdraw him or her 
at any time, without penalty.  If your child does withdraw, it will not affect you or your 
child in any way.  If you or your child chooses to withdraw, you may request that any 
data that has been collected be destroyed unless it is in a de-identifiable state. 
 
What about new information/changes in the study?  
 
If significant new information relating to the study becomes available which may relate 
to your willingness allow your child to continue to participate, this information will be 
provided to you. 
 
Voluntary Consent by Participant: 
 
By signing this consent form, you are agreeing that you have read it or it has been read to 
you. You fully understand the contents of this document and consent to your child taking 
part in this study.  All of your questions concerning this study have been answered. By 
signing this form, you are agreeing that you are the legal parent or guardian of the child 
who wishes to participate in this study described to you bySarah O’Rourke. 
 
 
____________________________________  Date: ________________ 
Participant's Parent/Legal Guardian’s Signature  
 
____________________________________  Date: ________________ 
Participant's Parent/Legal Guardian’s Signature 
 
 
It would be ok to contact me in the future about similar research projects (please check 
one):  
☐ Yes  ☐ No 
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APPENDIX C: CHILD ASSENT FORM 
 
UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
 
CHILD ASSENT FORM 
 
Study Title: Risk Factors for Anxiety in Children with AD/HD 
 
My name is Sarah O’Rourke. 
 
What is this about? 
 
I would like to talk to you about why some kids with AD/HD also have symptoms of 
anxiety.  I want to learn about your feelings and thoughts that have to do with anxiety. 
 
Did my parents say it was ok? 
 
Your parent(s) said it was ok for you to be in this study and have signed a form like this one. 
Your parent will be in the same building as you while you are participating in the study. 
 
Why me? 
 
We would like you to take part because you are between the ages of 8 and 15 and have 
AD/HD. 
 
What if I want to stop? 
 
You do not have to say “yes”, if you do not want to take part.  We will not punish you if you 
say “no”.  Even if you say “yes” now and change your mind after you start doing this study, 
you can stop and no one will be mad at you. 
 
What will I have to do? 
 
You will answer two different questionnaires that ask questions about your thoughts and 
feelings. 
 
Will anything bad happen to me? 
 
The questionnaires that you will fill out ask questions about your thoughts and feelings. 
Some kids feel uncomfortable answering these questions. You may skip any questions that 
you do not want to answer, and you may stop participating in the study at any time if you 
feel uncomfortable. 
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Will anything good happen to me? 
 
By being in this study, you may help other kids who also have AD/HD by helping us to 
learn about why some kids with AD/HD also have anxiety. 
 
Do I get anything for being in this study? 
Your family will receive a $10 gift card for being in this study. 
 
What if I have questions? 
You are free to ask questions at any time. 
 
If you understand this study and want to be in it, please write your name below. 
 
_____________________                              _______ 
Signature of child                                              Date   
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APPENDIX D: SUMMARY OF PARTICIPANT MEASURES 
 
Summary of Participant Measures 
Participant Measure 
Child Multidimensional Anxiety Scale for Children—Child Report (MASC-C) 
Nowicki-Strickland Locus of Control Scale for Children (NSLOC) 
 
Mother 
 
 
ADHD Rating Scale (ADHD-RS)* 
Conners Comprehensive Behavior Rating Scale (CBRS)* 
Alabama Parenting Questionnaire (APQ) 
Parenting Alliance Inventory (PAI) 
Beck Anxiety Inventory (BAI) 
Beck Depression Inventory (BDI) 
Conners’ Adult ADHD Rating Scale (CAARS) 
Computerized Diagnostic Interview Schedule for Children—IV (C-DISC-
IV) AD/HD, GAD, and SP modules* 
Multidimensional Anxiety Scale for Children—Parent Report 
 
Father 
 
BAI 
BDI 
CAARS 
* These measures were not completed by parents of children who had not received a 
diagnostic evaluation at the AD/HD Clinic in the six months prior to their participation in 
the study. 
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SUMMARY OF CHILD ASSESSMENT RESULTS 
 
Date of participation:  
 
Computerized Diagnostic Interview Schedule for Children IV (C-DISC-IV): 
<Child name> met research criteria for <diagnosis>. <Child name> did not meet 
research criteria for <diagnosis>. 
 
Conners’ Comprehensive Behavior Rating Scales (CBRS): 
Subscales Percentile 
DSM-IV: AD/HD—Predominantly 
Inattentive Type 
 
DSM-IV: AD/HD—Predominantly 
Hyperactive-Impulsive Type 
 
 
AD/HD Rating Scale (ADHD-RS): 
Subscales Percentile 
Inattention  
Hyperactive-Impulsive  
 
Multidimensional Anxiety Scale for Children (MASC): 
Subscales Percentile 
Physical Symptoms  
Harm Avoidance  
Social Anxiety  
Separation Anxiety  
Total  
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Description of Assessment Procedures 
 
Computerized Diagnostic Interview Schedule for Children IV (C-DISC-IV) 
The C-DISC-IV is a structured diagnostic interview that evaluates the presence or 
absence of various behavioral, emotional, and psychiatric disorders in childhood.  In this 
study the C-DISC-IV was administered to a parent to determine if AD/HD, Generalized 
Anxiety Disorder, or Social Phobia are present in the participant. 
 
Conners’ Comprehensive Behavior Rating Scales (CBRS) 
The CBRS is a behavior checklist that assesses AD/HD and a number of other common 
childhood conditions. The parent version of this scale was used in the current study to 
determine the degree to which child AD/HD symptoms deviated from expectations based 
upon comparisons with children of the same age and gender. 
 
ADHD Rating Scale (ADHD RS) 
The ADHD Rating Scale is an 18 item checklist that directly assesses AD/HD symptoms 
as defined by the Diagnostic & Statistical Manual of Mental Disorders - Fourth Edition 
(DSM-IV).  The parent version of this scale was used in the current study to determine 
the degree to which child AD/HD symptoms deviated from expectations based upon 
comparisons with children of the same age and gender. 
 
Multidimensional Anxiety Scale for Children (MASC) 
The MASC is a self-report measure that assesses anxiety symptoms in children. The child 
version of this scale was used in the current study to determine the presence and severity 
of child anxiety symptoms. 
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Table 1. Sample Characteristics 
 
Characteristic 
Child/Adolescent 
(N = 28) 
Mother 
(N = 28) 
   
 % (n) % (n) 
Sex   
 Male 71.43 (20) --  
 Female 28.57 (8) 100 (28) 
Race/Ethnicity   
 Asian 3.57 (1) --  
 Black/African American 10.71 (3) --  
 White 71.43 (20) --  
 Multiracial 10.71 (3) --  
 Did not report 3.57 (1) --  
Maternal Education Level   
 Some High School --  7.14 (2) 
 Completed High School --  7.14 (2) 
 Some College or Associate’s Degree --  17.86 (5) 
 Four year degree or higher --  39.29 (11) 
 Graduate Degree --  28.57 (8) 
Child Resides With   
 Both Parents 85.71 (24) --  
 Mother Only 14.29 (4) --  
 Father Only --  --  
Medication Status   
 Any AD/HD Medication 82.14 (23) --  
 Stimulant Medication for AD/HD 75.00 (21) --  
 Non-Stimulant medication for AD/HD 21.43 (6) --  
 Other Psychoactive Medication 3.57 (1) --  
aThe number of participants taking stimulant medication and non-stimulant medication is 
not equal to the total number of participants taking any medication for AD/HD because 
some participants were taking both stimulant medication and non-stimulant medication 
for AD/HD. 
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Table 2. Descriptive Statistics 
 
 
  M SD Minimum Maximum Skew Kurtosis
AD/HD Status 
 
ADHD-RS IA Severity (n = 28) 19.43 5.29 7 27 -.59 -.24
ADHD-RS HI Severity (n = 28) 15.39 7.73 2 27 -.26 -.66
CBRS IA Severity (n = 27) 77.85 11.27 53 90 -.75 -.51
CBRS HI Severity (n = 27) 72.48 17.12 39 90 -.53 -1.16
Predictors 
BAI mother transform. (n = 26) .79 .44 0 1.58 -.22 -.52
BDI mother (n = 28) 11.64 6.63 1 29 .47 .25
CAARS mother (n=25) 47.80 11.79 32 71 .68 -.78
BAI father transform. (n = 7) .67 .39 .30 1.32 .87 -.41
BDI father (n = 7) 8.29 7.39 1 20 .71 -.97
CAARS father (n = 6) 65.50 13.25 53 84 .35 -2.07
APQ Inconsist. Parenting (n = 28) -.16 .96 -2.04 1.71 -.03 -.26
PAI (n = 27) 74.52 19.51 23 97 -.86 .08
Outcome 
MASC-C (n = 28) 52.21 12.60 25 76 -.36 .34
MASC-P (n = 28) 50.25 15.34 23 78 .09 .76
Note. ADHD-RS = AD/HD Rating Scale; CBRS = Conners Comprehensive Behavior Rating 
Scale; IA = Inattention; HI = Hyperactivity-Impulsivity; BAI = Beck Anxiety Inventory; BDI = 
Beck Depression Inventory; CAARS = Conners Adult ADHD Rating Scale; APQ Inconsist. 
Parenting = Alabama Parenting Questionnaire Inconsistent Parenting subscale; PAI = Parenting 
Alliance Inventory; MASC-C = Multidimensional Anxiety Scale for Children – Child Version; 
MASC-P = Multidimensional Anxiety Scale for Children – Parent Version. 
Table 3. Correlations among Predictor and Outcome Variables 
 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. Child age --               
2. Child sex .01 --              
3. ADHD-RS 
IA Severity 
.06 .22 --             
4. ADHD-RS 
HI Severity 
-.34 .08 .47* --            
5. BAI mother 
transform. 
-.08 -.11 .18 .21 --           
6. BAI father 
transform. 
.78* -.18 .21 -.18 .34 --          
7. BDI mother .10 -.05 -.03 -.01 .67** .27 --         
8. BDI father .80 -.12 .21 -.10 .21 .95** .13 --        
9. CAARS 
mother 
-.11 .12 .13 .03 .31 .42 .37 .57 --       
10. CAARS 
father 
.17 -.64 .03 -.39 .43 .28 .53 -.01 -.52 --      
11. PAI .01 .03 .08 .01 -.09 -.05 -.07 -.07 .28 .31 --     
12. APQ -.02 -.24 -.01 .60** .16 .40 .15 .46 .20 -.19 -.07 --    
13. NSLOC .18 -.02 -.02 -.02 .03 -.04 -.15 -.11 .06 -.20 -.01 -.02 --   
14. MASC-C .04 -.33 .14 .13 .01 .64 .06 .67 .12 .27 .14 .26 .27 --  
15. MASC-P -.23 -.26 -.25 -.02 .27 -.13 .30 -.18 .20 .45 -.03 .04 .11 .27 -- 
Note. ADHD-RS = AD/HD Rating Scale; CBRS = Conners Comprehensive Behavior Rating Scale; IA = Inattention; HI = Hyperactivity-Impulsivity; 
BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; CAARS = Conners Adult ADHD Rating Scale; APQ = Alabama Parenting 
Questionnaire Inconsistent Parenting Scale; PAI = Parenting Alliance Inventory; MASC-C = Multidimensional Anxiety Scale for Children – Child 
Version; MASC-P = Multidimensional Anxiety Scale for Children – Parent Version. 
* p < .05, ** p < .01 
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Table 4. Logistic Regression Examining Maternal Psychopathology as a Predictor of C-
DISC-IV SP Diagnosis 
 
Predictor β SE Significance 
BAI mother 
transform. 
5.16 4.44 .25 
BDI mother -.22 .30 .46 
CAARS mother .22 .13 .08 
Note. BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; CAARS = 
Conners Adult ADHD Rating Scale 
Model 2 = 12.59, df = 3, p < .01
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Table 5. Post-Hoc Logistic Regression Examining Maternal Psychopathology as a 
Predictor of CBRS SP T-score ≥ 65 
 
Predictor β SE Significance 
BAI mother 
transform. 
.05 1.50 .97 
BDI mother -.21 .13 .12 
CAARS mother .22 .12 .06 
Note. BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; CAARS = 
Conners Adult ADHD Rating Scale 
Model 2 = 10.22, df = 3, p < .05 
 
Figure
 
 1: Chorpita and Barlow
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’s (1998) Model of Anxiety Development 
 
 
 
Figure
 
 2: Proposed Model of A
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nxiety Development in Children with AD/HD
 
  
